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This research is prompted by the need to improve interventions for addictive behaviors. 
Research has identified several key biobehavioral mechanisms involved in the risk and 
maintenance of addiction, which are prime targets for novel interventions. The present 
dissertation aims to test whether we can effectively modify several factors predictive of relapse 
(e.g., low distress tolerance (DT), behavioral avoidance, and hypothalamic-pituitary-adrenal 
(HPA)-axis dysregulation) using physical activity interventions. The rationale for employing 
exercise for this application is supported by (1) decades of research attesting to the capacity for 
exercise to beneficially tap multiple biobehavioral systems, (2) more recent research supporting 
the clinical utility of exercise in substance use disorder treatment, and (3) emergent evidence 
supporting the potential of exercise as an appealing and accessible alternative or add-on to 
standard care. Study 1 extends the results of recent work by our group, which demonstrated 
efficacy for exercise to reduce anxiety sensitivity (AS), a form of distress intolerance reflecting 
vulnerability to somatic arousal. The results suggest that gender may be a moderator of this 
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effect (Medina et al., 2014), with women responding less immediately than men. This 
observation underscores the need to further explore the treatment of distress-vulnerability in 
women, as well as potential merit in exploring alternatives to aerobic training. Accordingly, 
Studies 2 and 3 evaluated yoga for enhancing DT in females for whom distress vulnerability 
served to exacerbate maladaptive coping tendencies (e.g., smoking, overeating). Study 2 served 
as a proof of principle, wherein we examined the efficacy of Bikram yoga for enhancing DT in a 
sample of females with an elevated tendency to eat in response to stress or negative affect (i.e., 
conceptualized as an addictive behavior). Results were consistent with our hypothesis, showing 
that yoga enhanced self-reported emotional DT. Moreover, we found yoga primarily increased 
the absorption sub-facet of DT (defined as tendency for distress to absorb attentional resources), 
which, in turn, mediated reductions in self-reported emotional eating (Medina et al., 2015). In 
Study 3, we applied an 8-week hatha yoga (Vinyasa flow) intervention, aiming to address the 
contribution of elevated AS to early relapse in female smokers by targeting cortisol declines 
during the withdrawal phase of a quit attempt. Results did not support yoga as efficacious for 
altering cortisol, ameliorating subjective withdrawal, or achieving continuous abstinence post-
quit. We speculate this was in part due to poor intervention adherence, highlighting the 
importance of including intervention components to address motivation for health behavior 
change. We discuss other limitations and future directions from our findings across studies. 
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 1 
INTRODUCTION 
 Addictive behaviors, both substance and non-substance related, are a major global health 
concern. Substance use disorders (SUDs) represent the most prevalent and consequential form of 
behavioral addiction. These are defined excessive, prolonged patterns of alcohol, tobacco, and/or 
other drug use that leads to significant psychiatric distress and impairment in the daily 
functioning of the individual (American Psychological Association (APA), 2013). Considered a 
difficult-to-treat problem and leading risk factor for cardiovascular disease and early mortality 
(World Health Organization (WHO), 2009; Degenhardt & Hall, 2012; Whiteford et al., 2013), 
SUDs are one of the most costly conditions in the United States (US) and worldwide. In the US 
alone, SUDs have a lifetime prevalence rate of 20.8% (Kessler et al., 2005) and cost $600 billion 
annually (National Institute on Drug Abuse (NIDA), 2012).  
A variety of evidence-based pharmacological and behavioral treatment approaches exist 
for SUDs and other behavioral addictions (i.e., gambling). Still, there is much room to improve 
their effectiveness. Most individuals with SUDs do not initiate or remain in treatment (Copeland 
et al., 2006; Geraghty et al., 2012; Leeman et al., 2006; MacPherson et al., 2008; US Department 
of Health and Human Services, 1999), and the majority of those who attempt to reduce or quit 
using without aid are unsuccessful (Chapman & MacKenzie, 2010; Fiore et al., 1990). 
Furthermore, established interventions for SUDs are associated with high rates of relapse, even 
among treatment completers. Approximately 40-60% of patients who complete treatment for 
alcohol or illicit drug abuse end up relapsing (NIDA, 2012). For tobacco smoking, the relapse 
rate is as high as 85% (Copeland et al., 2006; Geraghty et al., 2012; Leeman et al., 2006; 
MacPherson et al., 2008). Thus, there is room for improving SUD treatment approaches. 
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Less research has been conducted on non-substance-related behavioral addictions. 
However, they are receiving increasing recognition as a cause for concern (APA, 2013; Potenza, 
2014; Yau & Potenza, 2015). In the Diagnostic and Statistical Manual of Mental Disorders, 5th 
Edition (DSM-5), the category Substance-Related/Addictive Disorders was established to 
classify substance and non-substance related behavioral addictions on a common spectrum, given 
relatedness in their clinical expressions (APA, 2013). However, only Gambling Disorder was 
included. Other non-substance and related behavioral addictions, such as those involving 
maladaptive or risky patterns of Internet use, sexual behavior, and eating, were considered but 
ultimately excluded from the Substance-Related/Addictive Disorders category, with the DSM-5 
task force advising further investigation into the phenomenology and impact of these conditions, 
in order to guide their future classification and treatment (Potenza, 2014).  
Mechanisms Across the Addictive Behaviors: Implications for Treatment 
 Though further progress is needed, there is ample evidence linking SUDs to other 
behavioral addictions. It appears that SUDs and non-substance behavioral addictions overlap in 
terms of the biobehavioral factors involved in their development and course (Potenza, 2014; 
APA, 2013). For example, altered dopamine receptor availability has been noted in SUDs, 
gambling disorder, and obesity. Important to note, abnormal dopamine functioning in localized 
D2, D3, and D4 receptor sites is typically correlated with altered reward and punishment 
sensitivity, which may help to explain maladaptive decision-making tendencies observed across 
addictive problems (Potenza, 2014; Yau & Potenza, 2015). Relatedly, clinical research suggests 
that, in some cases, eating patterns may function as a SUD. Findings in the eating literature 
converge in showing that under certain conditions repeated ingestion of hyperpalatable food (i.e., 
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high in fat, salt, sugar) is capable of triggering reward pathways that cause neuroendocrine and 
metabolic adaptations resembling those seen in drug addiction (Adam & Epel, 2007; Gearhardt, 
Grilo, Di Leone, Brownell, & Potenza, 2011). The context for this tendency to develop appears 
dependent on presence of stress coupled with biological diathesis for heightened biological 
stress-reactivity (Adam & Epel, 2007).  
In summary, these findings underscore the complexity and interrelation between 
mechanisms that drive addictive processes. Beyond the scope of addiction, research on 
transdiagnostic mechanisms has furthered our understanding of the overlap between forms of 
psychopathology more broadly (Barlow et al, 2010; Dozois, Seeds, & Collins, 2009; Sauer et al., 
2012). This work has suggested merit in treating addictive behaviors by targeting underlying 
emotional vulnerability factors. In a broad sense, emotional vulnerability refers to difficulty with 
respect to the ability to experience and cope with affective states leading to maladaptive 
consequences (Dozois, Seeds, & Collins, 2009; Leventhal & Zvolensky, 2015; Sauer-Zavala et 
al., 2012). In the past several decades, specialized attention, especially within the eating, 
anxiety/trauma, and substance use literature, has been paid to understanding the mechanisms 
underlying individual differences in emotional/affective vulnerability and its consequences. This 
has involved close examination of cognitive-affective and biological constructs implicated in 
emotional vulnerability (e.g., stress-reactivity, trait distress intolerance, emotion dysregulation. 
More recently, such factors have become subject to modification with interventions (Mansell, 
Harvey, Watkins, & Shafran, 2008; Sauer-Zavala et al., 2012). Indeed, this has led to several 
recent innovative behavioral treatments in the areas of affective disorders, personality disorders, 
SUDs/SUD comorbidity (Barlow et al., 2010; Mansell, Harvey, Watkins, & Shafran, 2008; 
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Neacsiu, Eberle, Kramer, Weismann, & Linehan, 2014). Efficacious modalities that address 
affective coping in their theoretical foundation, such as Dialectical Behavior Therapy (Linehan, 
1993), have tended to use cognitive-behavioral and mindfulness-based approaches to help 
patients learn new skills to improve their ability to cope with and adaptively regulate their 
emotions (Barlow et al., 2010; Mansell, Harvey, Watkins, & Shafran, 2008).  
Still, there is much to learn regarding the specific intervention needs of patients who 
present with various manifestations of affective vulnerability. In the context of addiction 
pathology, there are few controlled treatment studies that either directly tailor interventions for 
affect-vulnerable groups or evaluate lowered affective vulnerability as a mechanism of change 
leading to clinical improvement. First steps in advancing this research (and improving the 
treatment of addiction overall) will involve the identification of moderators and mechanisms of 
response through evaluation of easily accessible, preferred interventions with strong theoretical 
basis for reducing affective vulnerability through multiple biobehavioral avenues. The present 
dissertation evaluates behavioral health interventions for targeting two important affect-
vulnerability factors implicated in addiction maintenance and relapse: distress tolerance and 
hypothalamic-pituitary-adrenal (HPA) axis responding.  
Distress Tolerance (DT) 
Distress tolerance (DT) is defined as an individual-difference trait, reflecting both the 
perceived and actual incapacity to withstand negative experiential states (Brown, Lejuez, Kahler, 
Strong, & Zvolensky, 2005; Simons & Gaher, 2005). Individuals characterized by low DT 
appraise distress as highly unacceptable, threatening, and distracting (Simons & Gaher, 2005). 
Behaviorally, these persons display urgency to avoid or escape situations that provoke distress, 
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evidenced by tendencies for limited goal-persistence and maladaptive self-regulatory coping 
strategies (e.g., binge drinking, smoking, overeating; Leyro, Zvolensky, & Bernstein, 2011).  
Because low DT captures the susceptibility to negative experiential states, the construct is 
considered transdiagnostically relevant to psychopathology.  
Regarding the scope of the DT construct, Simons and Gaher (2005) have operationalized 
DT as facets involved in the process of managing and regulating non-specific emotional distress. 
These facets include: (1) one’s general perceived Tolerance of negative or threatening emotions, 
(2) one’s Appraisal or value judgment about feeling distressed or upset, as well as (3) the 
resulting Absorption of attention in the distress itself, and (3) the propensity for action aimed at 
Regulation or reduction of distress (Simons & Gaher, 2005). In support of this conceptualization, 
scores on the self-report based Distress Tolerance Scale (DTS; Simons & Gaher, 2005) have 
predicted symptom severity and problem behavior in a range of clinical populations (Anestis et 
al., 2007; Leyro et al., 2010).  
Other researchers, however, have made distinctions between cognitive/affective versus 
physical/somatic distress vulnerabilities (Leyro, Zvolensky, & Bernstein, 2011; Zvolensky et al. 
2008; Zvolensky et al., 2011), as evidenced by the array of lower-order constructs and related 
measures that have emerged in the study of low DT and its consequences (Leyro, Zvolensky, & 
Bernstein, 2011). For example, an identified risk factor for anxiety disorders is the fear of 
somatic arousal. Termed anxiety sensitivity (AS), this construct strongly predicts clinical anxiety 
disorder status and has thus become a crucial intervention target for anxiety disorders (Reiss, 
1991; Reiss & McNally, 1985), as well as for tobacco smokers with comorbid anxiety 
(Morissette et al., 2007). Other forms of low DT implicated in risk for psychopathology include 
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intolerance of frustration, situations defined by ambiguity, and physical pain (Leyro, Zvolensky, 
& Bernstein, 2011).  
Both self-report and behavioral measures have been developed to tap these various 
manifestations of low DT (Leyro, Zvolensky, & Bernstein, 2011). However, in line with diverse 
theoretical frameworks, there is no established gold standard approach to measuring DT across 
the distinct, related forms of psychopathology, and little evidence exists on the relative 
sensitivity to treatment among DT measures (McHugh & Otto, 2012; Zvolensky, Bernstein, & 
Vujanovic, 2011).  
As summarized by Leyro et al. (2011), overall data has been somewhat inconclusive as to 
whether domain-specific manifestations of distress intolerance represent constructs distinct from 
general low emotional distress tolerance. Towards establishing consensus in the field regarding 
its theoretical scope and characteristics, a recent factor analysis has been conducted among self-
report DT measures (McHugh & Otto, 2012). Results suggest that lower-order constructs may be 
subsumed under a global emotional DT construct, as scores across measures appear to most 
strongly load onto a general DT factor (McHugh & Otto, 2012). Still, domain-specific self-report 
measurements with psychometrically sound properties continue to be used given the relevance of 
their items for identifying clinically-specific concerns and their usefulness in establishing clinical 
severity norms (Leyro, Zvolensky, & Bernstein, 2011).  
This literature was used to inform our approach to studying DT in the present 
dissertation. Depending on the research question and clinical population of interest in each of the 
three studies, we considered ways to address both broad DT and AS. When appropriate for 
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describing elevated AS as a more-specific manifestation of low DT, we used the terms “low DT” 
and “AS” interchangeably.  
Because low DT leads to coping-oriented substance use, it is considered a maintaining 
factor of substance abuse and addiction. This is especially the case in individuals with comorbid 
psychopathology (Bonn-Miller et al., 2009; Brown, Lejuez, Kahler, & Strong, 2005; Buckner, 
Keough, & Schmidt, 2007; Cooper, Frone, Russell, & Mudar, 1995; Simons & Gaher; 2005; 
Zvolensky et al., 2009). This has been extensively studied in the context of nicotine addiction. 
Over the past several decades, observational, experimental, and clinical intervention studies have 
found that individuals low in DT, as defined by elevated AS or intolerance of frustration, classify 
as a difficult-to-treat subgroup of nicotine users who are particularly prone to relapse (Brown, 
Lejuez, Kahler, & Strong, 2005). In one study, smokers with high AS, as evidenced through 
heightened reactivity to a laboratory biological CO2 gas inhalation challenge, had been unable to 
achieve a full week of abstinence during any of their previous quit attempts (Zvolensky, Feldner, 
Eifert, & Brown, 2001).  
Prospective studies have demonstrated similar findings for individuals with low DT. 
Specifically, low emotional DT predicts greater withdrawal symptom severity and shorter time to 
lapse following a tobacco quit attempt (Brown et al., 2005; Brown et al., 2009; Brown et al., 
2008; Abrantes et al., 2008). Such tendencies for early lapse, as well as subsequent relapse, are 
also evidenced by low DT smokers who receive gold-standard treatment (Abrantes et al., 2008; 
Brown, Lejuez, Kahler, & Strong, 2005). In the context of RCTs, early post-quit lapse (i.e., that 
occurs on or shortly after the scheduled quit date) tends to be preceded by a sharp increase in 
negative affect (Abrantes et al., 2008; Brown, Lejuez, Kahler, & Strong, 2005). Given the 
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negative-reinforcement value of smoking, these early lapses have been understood to reflect 
individuals’ efforts to escape the aversive sensations of acute nicotine withdrawal (Abrantes et 
al., 2008; Brown, Lejuez, Kahler, & Strong, 2005; Shiffman & Waters, 2004; West, Hajek, & 
Belcher, 1989; Zvolensky, Feldner, Eifert, & Brown, 2001). Further highlighting their pervasive 
behavioral avoidance tendencies, low DT smokers are also more likely to dropout from 
treatment. Together, these findings suggest that improving SUD treatment may require 
addressing low DT. 
Hypothalamic-Pituitary-Adrenal (HPA) Axis Functioning 
Stress plays a significant role in mental health. Most forms of psychopathology have been 
understood through a diathesis-stress framework, which recognizes the interactive role of 
biological factors (e.g., genetics, biochemistry) and environmental stressors in predicting the 
onset and course mental disorders (Goforth, Pham, & Carlson, 2011; Salomon & Jin, 2013; 
Zuckerman, 1999). Both disorder-specific and general diathesis-stress models have been 
proposed to explain the development of psychopathology (Salomon & Jin, 2013; Zuckerman, 
1999). Common to these models is the idea that physiological stress mechanisms play a critical 
role in the onset and course of illness. The central component of biological stress responding is 
the HPA-axis, which governs the release of various neurochemicals and hormones (e.g., CRH, 
ACTH, and cortisol) that operate along a negative feedback loop in order to effectively regulate 
the release of one another (Zuckerman, 1999). Pertinent to the expression of psychopathology, 
HPA-axis activity is critically involved in motivated behavior, threat responding, and effective 
regulation of emotional stress (Zuckerman, 1999). The HPA-axis is also involved in a range of 
processes beyond stress perception. For example, it is critically involved in the regulation of 
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homeostatic mechanisms (e.g., neuroendocrine, immune, metabolic, hormonal) required for 
survival and overall systemic health. These systems are known to become disturbed under 
chronic stress, and, if not effectively managed, this disruption may result in serious health 
consequences including the development of chronic disease (Guilliams & Edwards, 2010).  
Given the known contribution of psychosocial stress to the development, maintenance, 
and relapse of SUDs, as well as the pervasive involvement of HPA-axis activity in all biological 
systems, investigations of the underpinnings of addiction have paid special attention to the role 
of the HPA-axis in SUDs (Adinoff, Junghanns, Kiefer, & Krishnan-Sarin, 2005; Goeders, 2002; 
2003; Stephens & Wand, 2012). Habitual substance use disrupts regulatory characteristics of the 
HPA-axis, resulting in physiological adaptations and potential consequences depending on the 
nature of the dysregulation.  
One potential consequence is altered glucocorticoid receptor sensitivity, which alters 
cortisol stress-reactivity and recovery patterns, impacting one’s ability to cope effectively, both 
emotionally and behaviorally, with stressful situations (Adinoff, Junghanns, Kiefer, & Krishnan-
Sarin, 2005; Frederick, 1998; Koob & Mohl, 2001). Indeed, the effects of altered (especially 
reduced) glucocorticoid receptor sensitivity have been implicated in the onset and relapse of 
cocaine, nicotine, and alcohol use disorders (Adinoff, Junghanns, Kiefer, & Krishnan-Sarin, 
2005; Frederick, 1998; Koob & Mohl, 2001). Altered glucocorticoid activity in the HPA-axis 
activity can also result in neuroplasticity in pathways that reinforce the reward potential of 
addictive substances, thereby exacerbating the addictive behavior (Koob & Mohl, 2001). This 
may be particularly salient maintenance factor for individuals driven by the negative 
reinforcement of their drug use. Merging schools of thought in the context of maladaptive eating, 
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a review by Adam & Epel (2007) on stress, eating, and the reward system suggests that the 
propensity for heightened biological stress reactivity, coupled with cognitive affective intention 
to diet, moderates the degree to which individuals engage in tendencies of emotional stress-
eating (Adam & Epel, 2007). 
Cortisol dysregulation also appears to be implicated in substance use relapse. In stimulant 
use disorders, this appears to be related to hypercortisolism caused by habitual use. In daily 
tobacco smokers (compared to non-smokers), for example, unstable but repeated elevations in 
cortisol, as well as amplified cortisol-awakening responses, are observed (Friedman et al., 1987; 
Steptoe & Ussher, 2006). Pointing to how this is related to relapse, on the first day following 
tobacco deprivation (2-24 hours post-cessation), there is a sharp plummet in cortisol 
concentration caused by the absence of nicotine (i.e., proposed by authors as representing a 
rebound effect; Cohen, al ‘Abasi, & Collins, 2004; Pomerleau, Garcia, Pomerleau, & Cameron, 
1992; Ussher et al., 2006). Though levels begin to increase steadily after several days, this initial 
drop in cortisol is associated with withdrawal symptom intensity and early relapse (al’Absi et al., 
2004; Steptoe & Ussher, 2006). Efforts understand the clinical utility of targeting cortisol in 
order to achieve improved early abstinence outcomes are warranted. 
Targeting Emotional Vulnerability Facilitates Treatment Efficacy 
 Initial research suggests that targeting DT and the HPA-axis facilitates treatment efficacy 
for addictive problems. Early-stage intervention development efforts have begun targeting DT in 
the context of nicotine dependence. The components of these interventions have drawn from 
evidence-based approaches used in other low DT-associated forms of psychopathology (e.g., 
personality, eating, and anxiety disorders). Brown and colleagues (2008), for example, 
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implemented a mindful acceptance-based augmentation to standard cognitive behavioral therapy 
(CBT) to target DT in smokers with a history of repeated relapse (Brown et al., 2013). Among 
those who completed the trial, 81% were able to remain abstinence for longer than 72 hours 
(43% maintained abstinence for over one month), suggesting that low-DT smokers were able to 
improve their cessation success with this adjunct intervention (Brown et al., 2013). Moreover, 
82% of participants indicated that the skills learnt from this adjunctive module were either 
“very” or “extremely” useful in helping participants quit smoking, suggesting the intervention 
was well tolerated (Brown et al., 2008). Though these results preliminary results appear 
promising, the lack of a control comparison group renders our inability to determine whether the 
acceptance-based component was directly responsible for these outcomes, and, thus, that the 
mechanism of therapeutic action was indeed DT.  
Meanwhile, the controlled pilot investigations that have been conducted in smokers 
encourage strategies using systematic distress-induction (Schmidt, Raines, Allan, & Zvolensky, 
2016; Zvolensky et al., 2008). Illustratively, a recent RCT among anxiety-sensitive smokers 
showed that a behavioral interoceptive (i.e., internal sensation) exposure intervention aided 
smoking cessation through the mechanism of reduced AS (Schmidt, Raines, Allan, & Zvolensky, 
2016; Zvolensky et al., 2008).  
Rationale for Targeting Emotional Vulnerability with Exercise  
 Rationale for the application of exercise to address emotional vulnerability factors is 
supported by several lines of research. First, evidence establishes exercise as a stress-reducing 
intervention mediated by its regulatory effect on the HPA-axis (Mastorakos, Pavlatou, Diamanti-
Kandarakis, & Chrousos, 2005; Ross & Thomas, 2010; Stranahan & Mattson, 2008). Second, 
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exercise appears to have effects on the low DT sub-construct AS (Broman-Fulks, Berman, 
Rabian, & Webster; Broman-Fulks & Storey, 2008; Smits et al., 2008). Third, exercise has 
shown benefit as a supplementary intervention to aid traditional SUD treatment (Nelson, 2013). 
Fourth, exercise has potential as an easily accessible modality without the stigma associated with 
traditional mental health treatments. 
Abundant translational and experimental research has been conducted on the effects of 
exercise on stress in animals and humans. This work indicates that one way exercise may reverse 
the maladaptive effects of chronic, oxidative stress on mental health is by targeting pro-
inflammatory cytokines (Mastorakos, Pavlatou, Diamanti-Kandarakis, & Chrousos, 2005; Ross 
& Thomas, 2010; Stranahan & Mattson, 2008). Anti-inflammatory potential has been most-
supported for voluntary repeated vigorous-intensity aerobic training (Mastorakos, Pavlatou, 
Diamanti-Kandarakis, & Chrousos, 2005). Another path by which exercise can reduce 
inflammatory stress is by regulating cortisol secretion patterns in the HPA-axis. A bout of 
intense exercise acts as a brief systemic stressor, such that over time, repeated exercise has a 
lowering effect on basal cortisol and overall tonic effect on acute HPA-axis-reactivity to stress 
(Hamer, Taylor, & Steptoe, 2006).  
A budding line of clinical research on yoga suggests the ancient practice may have 
similar anti-inflammatory and stress-reducing potential to aerobic exercise. Some researchers 
have proposed yoga is able to exerts its effects on stress via alternating between sympathetic 
activation (i.e., through the completing and transitioning through asana (physical postures)) and 
parasympathetic activation (i.e., through meditation and breathing exercises; Ross & Thomas, 
2010; Sarang & Telles, 2006; Telles et al., 2013). Recent evidence suggests that both a bout of 
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light-intensity (i.e., stretch-based, restorative) and vigorous-intensity yoga can reduce cortisol 
levels in women (Sullivan et al., 2017). However, results also suggest that practitioners find 
vigorous intensity yoga (termed “power yoga”) more enjoyable and energizing, suggestive of 
intense-yoga’s affect regulation potential. Furthermore, initial evidence suggests that a regular 
vigorous-intensity yoga practice can effects similar to aerobic exercise on stress-reactivity. The 
parent trial to our Study 2 showed that an 8-week Bikram hot-yoga intervention was able to 
reduce cortisol reactivity to stress for women with heightened baseline stress-reactivity patterns 
(Hopkins et al., 2016). Further exploration into the comparison between yoga and other physical 
activity is warranted. 
Regarding DT, numerous RCTs in the area of anxiety supports efficacy for a brief (e.g., 
2-week) vigorous-intensity exercise intervention to reduce elevated AS in college students with 
subclinical anxiety (Smits et al., 2008; Broman-Fulks et al., 2008) and in individuals with 
clinical PTSD (Fetzner & Asmundson, 2015). Importantly, Smits and colleagues’ (2008) study 
conducted a test of mediation that confirmed enhanced anxiety tolerance as a driving mechanism 
of clinical anxiety symptom improvement with exercise (Smits, Powers, Cho, & Telch, 2004). 
Smits and colleagues have since applied these findings to smokers warranting AS 
reduction in their RCT that evaluated an aerobic exercise augmentation to standard group-based 
CBT for smoking cessation (Smits et al., 2012; 2016). Results revealed that exercise enhanced 
treatment effectiveness by mitigating the risk of high-AS status. Specifically, rates of point-
prevalence abstinence and sustained abstinence following a target quit-date was higher for 
participants with higher AS at baseline randomly assigned to 15-week exercise + standard 
treatment (ST) (vs. a ST + wellness education control condition) at each assessment point than 
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for lower-AS patients (Smits et al., 2016). Furthermore, among these high-AS participants, there 
were also reductions in AS as the result of exercise (Smits et al., 2016).  
Complementing these results, a recent pilot trial examined efficacy of a stand-alone 
exercise intervention (16-week gym membership) among adults with alcohol use disorders 
(AUD; Nelson, 2013). Findings demonstrated AS reductions at both the 8-week and 16-week 
follow-up for AUD patients with clinically elevated AS scores at baseline (vs. those without). 
Moreover, the greatest gains were seen in high-AS AUD patients who exercised for at least 150 
minutes per week over the 16-week intervention period (Nelson, 2013). This finding is consistent 
with the results of dose-effectiveness trials on exercise for the treatment of psychopathology in 
depression and anxiety, which advocate for exercise practice that meets or exceeds public-health-
recommended standard (Asmundson, et al., 2013; DeBoer, Powers, Utschig, Otto, & Smits, 
2012; Dunn, Trivedi, Kampert, Clark, & Chambliss, 2005; Stathopoulou et al., 2006; Wipfli, 
Rethorst, & Landers, 2008). 
It is worth noting that, though the evidence on exercise in the realm of AS has been 
consistent, it is unclear whether exercise is able to tap other low DT facets relevant to addiction. 
In fact, a recent trial examining brief exercise exposure among participants with anxiety concerns 
showed the contrary. This RCT found that a vigorous aerobic bout of exercise reduced AS (i.e., 
reactivity to a post-exercise CO2 challenge), but not other distress vulnerabilities, emotional DT 
and physical discomfort intolerance (DI) (Broman-Fulks, Kelso, & Zawilinski, 2015). The 
inconclusive nature of these findings warrants additional research attention. Future research calls 
for studies to examine patient-characteristic moderators in the exercise-DT relation, and, more 
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specifically, to evaluate exercise to treat various facets of low DT and in the context of various 
SUDs. 
Despite these mixed results from the DT literature, researching consistently documents 
exercise as beneficial to SUDs, suggesting that it may aid in SUD recovery through a variety of 
mechanisms (both related and unrelated to low DT). Findings of several smoking cessation RCTs 
(Marcus et al., 1999, 2013, 2015), for example, parallel the results of Smits et al. (2016) by 
showing CBT-enhancement with vigorous-intensity exercise. Importantly, Marcus and 
colleagues also gathered initial support for yoga, a mind-body alternative to aerobic training. Her 
research group first evaluated a 12-week CBT-adjunctive aerobic exercise intervention (Marcus, 
et al., 1999) and next, an 8-week CBT-adjunctive hatha yoga intervention (Marcus et al., 2013, 
2015). Their results demonstrated comparable augmentative potential for both forms of exercise. 
As a particularly pertinent component of their results to relapse-vulnerable smokers with low-
DT, they also found that adjunct physical activity attenuated participants’ nicotine withdrawal 
(Marcus et al., 1999; 2013, 2015). These findings may reflect a dose-response effect of exercise. 
This is substantiated by emerging data suggesting that acute vigorous-intensity aerobic exercise 
or yoga may be required to target the biobehavioral mediators (e.g., cortisol levels, craving) of 
nicotine withdrawal (Taylor, Ussher, & Faulkner, 2007; Ussher, Taylor, & Faulker, 2012).  
Furthermore, beyond the area of nicotine dependence, regular physical activity can treat 
comorbid mental health problems of inpatients with alcohol and illicit substance use disorders 
(Linke & Ussher, 2014; Zschucke, Heinz, & Strohle, 2011). Encouraging its capacity to address 
emotional distress-vulnerability specifically, exercise is especially known to reduce SUD-
concomitant anxiety and depression (Palmer, Vacc, & Epstein, 1988; Zschucke, Heinz, & 
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Strohle, 2011). The general health benefits of exercise in SUDs have also encouraged its 
application. Indeed, a recent review paper concluded that regular exercise training enhances 
quality of life and facilitates health-risk reduction from substance use disorders (Linke & Ussher, 
2014). As a final practical note, exercise is a readily available practice that lacks the association 
with stigma of traditional therapies. Accordingly, in addition to aiding in SUD-recovery, it may 
serve as a particularly appealing behavioral health alternative for individuals who cannot access 
conventional treatments or avoid these for other reasons (i.e., low DT).  
In summary, previous research calls for improving the effectiveness, feasibility, and 
tolerability of treatments for SUDs. Novel interventions are particularly warranted that can 
address the contribution of low DT to SUD maintenance, relapse, and treatment attrition. 
Treatments for enhancing DT in psychopathology to date have involved mindful acceptance and 
behavioral exposure; and so far, these techniques appear effective in low DT substance users 
with tobacco addiction. Exercise (especially of the aerobic type) emerges as another efficacious 
behavioral candidate for addressing low DT. In addition, exercise holds practical and health-
promoting potential for addressing public health burden of SUDs.  
Evidence of the clinical utility for exercise to target low DT directly has been 
demonstrated among high-AS tobacco smokers. Given the nature and timing of relapse within 
for smokers with low DT, application of high-intensity (vigorous) exercise is particularly 
encouraged by its capacity to attenuate putative mechanisms of nicotine withdrawal. Still, 
knowledge regarding the exercise-DT relation is limited, especially in the context of SUDs. In 
patients with subclinical anxiety, acute aerobic exercise appears capable of reducing AS but not 
general emotional DT or other-related domain-specific facets (e.g., intolerance of discomfort). In 
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conclusion, additional research testing whether multi-modal acute and regular exercise can tap 
facets of DT is needed, especially in relapse-vulnerable SUDs patients.  
Conclusion and Overview of Dissertation Studies 
Clearly needed are treatments with potential for addressing the dynamic interplay of 
biobehavioral risk and maintaining factors implicated in addiction pathology, while addressing 
effectiveness limitations (e.g., accessibility, attrition). Through three separate RCTs, we evaluate 
aerobic exercise and yoga for targeting affect-vulnerability factors associated with addictive-
behavior maintenance and relapse (i.e., low distress tolerance (DT), hypothalamic-pituitary-
adrenal (HPA)-axis dysregulation). The long-term objective of this initial line of research is to 
better understand the role of exercise in mental health treatment. By uncovering mechanisms of 
treatment response with exercise, we hope to promote its utility for the appropriate clinical 
groups who may benefit from integrating exercise as either a stand-alone or augmentative 
treatment for addiction. 
Study 1. Does the efficacy of a brief aerobic exercise intervention for reducing anxiety 
sensitivity vary as a function of gender? 
A moderate-to vigorous-intensity exercise program is emerging as a promising strategy 
for reducing AS. Identifying determinants of response will further elucidate the potential utility 
of exercise as treatment for populations with elevated AS. Prior literature suggests that the 
effects of exercise on mental health may vary as a function of gender, with men benefitting more 
than women (Elliot et al., 2012; Bhui & Fletcher, 2000; Hunt-Shanks, Blanchard, & Reid, 2009). 
The present study tested the hypothesis that the effect of exercise on AS would vary as a function 
of gender, such that the effect would be stronger for men than for women. We tested this 
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hypothesis using the data from our group’s previous study (Smits et al., 2008, cited above) in 60 
participants with elevated levels of AS who were randomly assigned to a two-week exercise 
intervention [EX] or a waitlist control condition [WL].  
Study 2. Can the practice of alternative, mind-body yoga enhance emotional distress 
tolerance in distress-vulnerable women with addictive coping tendencies? 
Decades of research devoted to the study of transdiagnostic affect intolerance identify 
low affective distress tolerance (DT) and related (e.g., anxiety sensitivity (AS), discomfort 
intolerance) as explanatory mechanisms for the maintenance of and interrelation between 
anxiety, depressed mood, and substance use pathology (Leventhal & Zvolensky, 2015). Hatha 
yoga encourages one to implement experiential tolerance and acceptance (i.e., one of the goals of 
mindfulness) and non-reaction in the face of physical and psychological discomfort. It therefore, 
emerges as a potential strategy for increasing DT. To test whether a hatha yoga intervention can 
enhance DT this study randomly assigned females high in emotional eating in response to stress 
(N = 52) either to an 8-week, twice-weekly hatha (Bikram) yoga intervention or to a waitlist 
control condition. Self-reported DT scores and emotional eating urges were measured at 
baseline, weekly during treatment, and 1-week post-treatment and compared across time between 
groups. Moreover, we examined DT as a potential mechanism of change accounting for 
reductions in an index of stress and addiction-related psychopathology (emotional eating). 
Study 3. Can a yoga practice aid in smoking cessation by way of targeting biobehavioral 
nicotine withdrawal?   
 The call for the development of specialized interventions for smokers at heightened risk 
for relapse is guided by the selection hypothesis of smoking prevalence, which posits that 
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smokers who are not able to quit successfully are “burdened” by specific characteristics that 
make it more challenging to quit (Hughes & Brandon, 2003).  
Accordingly, Study 3 is informed by results from Studies 1 and 2, as well as by basic 
experimental research on the putative biobehavioral processes underlying smoking relapse in at 
risk populations. This study randomly assigned 50 female smokers low in DT (i.e., elevated AS) 
to either an 8-week yoga intervention [YOGA] or a waitlist control [WL] prior to undergoing a 
self-guided quit attempt. Our primary aim was to investigate the effect of yoga on cortisol. We 
hypothesized participants assigned to the yoga condition (relative to waitlist) would evidence 
greater reductions in salivary cortisol levels form pre-to-post intervention (ad-libitum). 
Furthermore, during the initial 12-hrs of a post-intervention quit attempt, we hypothesized yoga 
participants would self-report lower withdrawal symptom severity and evidence slighter declines 
in salivary cortisol (relative to the previous day). Our secondary aim was to evaluate the efficacy 
of yoga for smoking cessation. Measuring quit-success at 1-week follow-up, we hypothesized 
YOGA would evidence lengthier abstinence duration (in days) than WL. 
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STUDY 1 - Gender Moderates the Effect of Exercise on Anxiety Sensitivity 
Accruing empirical evidence supports exercise as a therapeutic strategy for improving 
mood and anxiety disorders (Asmundson et al., 2013; DeBoer, Powers, Utschig, Otto, & Smits, 
2012), especially for mild to moderate major depressive disorder (MDD; Dunn, Trivedi, 
Kampert, Clark, & Chambliss, 2005; Singh, Stavrinos, Scarbek, et al., 2005; Veale, Le Fevre, 
Pantelis, et al., 1992). A meta-analysis aggregating the results of randomized, controlled trials for 
MDD revealed a large effect (d = 1.42; Stathopoulou et al., 2006) supporting the overall 
effectiveness of exercise interventions for improving clinical depression.  
Though less extensively studied, exercise has also shown initial efficacy for treating 
anxiety disorders (Petruzello et al., 1991; O’Connor, Raglin, & Martinsen, 2000; Stathopoulou et 
al., 2006; Wipfli, Rethorst, & Landers, 2008). A recent quantitative review evaluated the 
effectiveness of exercise for anxiety in both clinical and non-clinical adult samples. The 49 
RCTs included exercise interventions at the moderate-to-vigorous intensity ranging from an 
acute bout to five times per week for a duration of 30 to 90 minutes per session. Results showed 
exercisers to fare significantly better than those in no-treatment control groups (Hedge’s g = -
0.48), and either comparable to or better than those in other active treatments commonly used to 
treat anxiety (Hedge’s g = -0.19), such as cognitive behavioral therapy (CBT), relaxation 
therapies (e.g., meditation, light exercise, yoga), group psychotherapy, and stress management 
education. Moreover, their results indicated that exercise can yield outcomes comparable to 
medication (Wipfli, Rethorst, & Landers, 2008). 
_______________ 
Study published in peer reviewed journal: Medina, J. L., Hopkins, L. B., Powers, M. B., Baird, S. O., & 
Smits, J. A. J. (2015). The effects of a hatha yoga intervention on facets of distress tolerance. Cognitive 
Behaviour Therapy, 44, 288-300. I served as primary author for this work. 
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Similarly, because exercise can induce somatic arousal in a repeated, systematic, and 
prolonged fashion, it may effectively serve as fear extinction training. Indeed, within standard 
evidence-based cognitive-behavioral interventions for panic disorder (PD), this type of 
interoceptive exposure appears to be critical for symptom improvement (Smits, Powers, Cho, & 
Telch, 2004), likely by way of reducing anxiety sensitivity (AS; fear of anxiety sensations and 
their consequences; McNally, 2002; Smits, Julian, Rosenfield & Powers, 2012; Smits, Berry, 
Tart, & Powers, 2008; Smits et al., 2007). Given the identified role of AS as a cognitive-affective 
risk and maintenance factor for anxiety disorders (e.g., panic disorder; McNally, 2002; Olatunji 
& Wolitzky-Taylor, 2009) as well as for related problems characterized by maladaptive coping 
behaviors and poor emotion regulation (e.g., substance use, binge eating, PTSD; Taylor, 1999), a 
moderate-to vigorous-intensity exercise program may prove beneficial, not only for those with a 
PD diagnosis, but also for reducing AS in at-risk populations more broadly.  
Our group extended previous work by Broman-Fulks et al. (2004) by demonstrating that 
a brief (2-week) moderate-intensity aerobic exercise intervention in adults with elevated scores 
(≥ 25 indicating possible clinical problems; Peterson & Plehn, 1999, p. 70) on the Anxiety 
Sensitivity Index (ASI; Reiss & McNally, 1985) led to clinically significant changes in AS from 
pretreatment through 3-week follow-up (Smits et al., 2008). Indeed, clinically significant change 
(requiring reduction of scores ≥ two standard deviations below the baseline sample mean) was 
observed in 88% of exercising participants (Smits et al., 2008), with mean ASI decreasing from 
33 at pretreatment to 14.5 at posttreatment and to 11.5 by 3-week follow-up. Beyond building 
additional support for a brief exercise regimen for reducing AS, we showed that these clinically 
meaningful reductions in AS resulting from exercise mediated subsequent improvements in self-
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reported depressive and anxiety symptoms (see Smits et al., 2008). This trial was the first to 
directly evaluate altered-AS as a causal mechanism of the anxiolytic and antidepressant effects 
of exercise. Identifying moderators of exercise’s efficacy for reducing AS may further elucidate 
the nature of the AS-exercise relation, and thus, the potential utility of exercise as treatment for 
anxiety disorders and related aforementioned problems associated with elevated AS. 
Prior evidence from outside the AS literature suggest that the effects of exercise on 
mental health may vary as a function of gender, with men benefitting more than women (Elliot et 
al., 2012; Bhui & Fletcher, 2000; Hunt-Shanks, Blanchard, & Reid, 2009). For example, a recent 
investigation revealed a stronger inverse relation for males more than for females between 
physical activity frequency and frequency of depressive symptoms and consideration of suicide 
(Elliot et al., 2012). In addition, the meta-analysis by Wipfli and colleagues (2008) revealed 
significant effect sizes in mixed-gender and male-only samples, but not in female-only samples, 
suggesting that there may be meaningful gender differences in the efficacy of exercise 
interventions for reducing anxiety symptoms. Such differences could have important 
implications for clinical practice (e.g., matching strategies, need for additional strategies) and 
help guide research on the understanding of the mechanisms of action of exercise for mental 
health conditions.  
Building upon the aforementioned work, the present study tested the hypothesis that the 
effect of exercise on AS would vary as a function of gender, such that the effect would be 
stronger for men than for women. We tested this hypothesis using data from our previously 
published study (Smits et al., 2008). In this study, participants with elevated levels of anxiety 
sensitivity (N = 60) were randomly assigned to a 2-week exercise intervention [EX] or a waitlist 
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control condition [WL]. Because Smits and colleagues (2008) found no significant difference 
between the two slightly different exercise conditions in reductions of AS (with both showing 
greater decreases in ASI scores from pretreatment to follow-up compared to WL), we collapsed 
across exercise conditions to form a single EX group for the present study. Using this data set, 
we investigated whether there were gender differences in the effects of exercise on AS in 
response to a brief, 2-week programmed exercise. More specifically, we predicted a significant 
3-way interaction, such that the change in ASI over time in EX relative to WL would be greater 
for males than for females. 
Method 
 
Participants 
Study participants (N = 60; 45 Female; MAge = 20.68, SD = 5.80) consisted of (1) 
undergraduate students at a medium-sized private university in the Southwest (N = 50; 38 
Female; MAge = 20.40, SD = 5.03) and (2) community individuals in the Boston area (N = 10; 7 
Female; MAge = 22.10, SD = 8.95). Undergraduate participants were recruited from classroom 
survey screenings in introductory psychology courses. In the Southwest sample, 182 of the 286 
potentially eligible participants (i.e., with surveys indicating clinically elevated AS ≥25) 
indicated interest in participating and were contacted by study staff to complete a phone 
interview. Of the 91 deemed eligible, 50 participants enrolled, and were given course credit for 
participation. Participants from the Boston area site were recruited from community 
advertisements near a large public university. Of the 91 surveyed at the Boston site, 30 
completed phone interview, and 10 interested participants were enrolled (9 students and 1 person 
from larger community area; see Smits et al., 2008).  
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All participants met the following entry criteria: elevated anxiety sensitivity (indexed by 
ASI score ≥ 25; Peterson & Reiss, 1992); absence of physical conditions that could be 
exacerbated by exercise; body mass index < 35; no current involvement in an exercise program 
(i.e., ≤ one aerobic exercise session per week); no recent change in psychotropic medications 
(e.g., stabilized for at least four weeks for antidepressants and two weeks for benzodiazepines); 
and no current psychotherapy. The study sample consisted primarily of students (98%) who were 
Caucasian (71%). Only 1 participant reported taking current psychotropic medication (prescribed 
Adderall for ADHD symptoms). 
Measures 
 
Demographics. Following study enrollment and one week prior to the intervention (i.e., pre-
treatment), self-reported demographic information was collected from each participant.  
Anxiety Sensitivity. The Anxiety Sensitivity Index (ASI) is a 16-item validated measure of 
anxiety sensitivity, defined as the fear of anxiety-related sensations and their consequences 
(Peterson & Reiss, 1992). On the ASI, respondents indicate on a 5-point Likert-type scale (0 = 
very little to 4 = very much) the degree to which anxiety symptoms are distressing (e.g., “It 
scares me when my heart beats rapidly”) and the concern about negative consequences of anxiety 
symptoms (e.g., “When I notice that my heart is beating rapidly, I worry that I might have a heart 
attack”). Normative studies indicate that scores above 25 indicate possible clinical problems 
(Peterson & Plehn, 1999). The ASI has sound psychometric properties in both clinical and 
nonclinical samples, including adequate construct validity (McNally & Lorenz, 1987; Reiss, 
Peterson, Gursky, & McNally, 1986; Taylor, Koch, & McNally, 1992; Telch, Shermis, & Lucas, 
1989). The ASI was administered to all participants at four separate time points: pretreatment, 
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mid-treatment (1 week after exercise initiation), posttreatment (end of 2-week exercise program), 
and 3-week follow-up (i.e., three weeks following completion of exercise intervention). 
Intervention Procedures 
Exercise [EX]. The exercise dose for this intervention was guided by previous meta-
analyses, which documented that moderate-to-high-intensity exercise (e.g., 60-80% of maximum 
age-predicted heart rate) superior to low-intensity exercise (Wipfli et al., 2008). Accordingly, the 
intervention consisted of thrice-weekly 20-minute moderate intensity aerobic exercise sessions 
over two weeks (six sessions total), which were designed to elicit sensations of physiological 
arousal as a type of interoceptive exposure targeting their anxiety-related fears. Along with direct 
verbal instruction from the experimenter for the participant to attend to the sensations 
experienced, participants were asked by the protocol therapist to rate their level of subjective 
distress (assessed on a scale of “0 = not intense at all” to “100 = extremely intense”) every three 
minutes during exercise. At the first session, participants were provided with the rationale behind 
exercise for anxiety (Smits et al., 2008). Exercise was completed and supervised by CPR-
certified study personnel at the laboratory in a room furnished with treadmills and appropriate 
safety equipment (e.g., defibrillator); the exercise room featured a computer-controlled exercise 
training management system (Smooth® 7.1 HR Pro, InternetFitness.com, Inc., Mt. Laurel, NJ). 
The system allows for input of relevant data for each participant (resting and maximal heart rate, 
target heart rate, and session duration). The computer receives a heart rate (HR) signal from a 
Polar® transmitter (chest strap), allowing the experimenter to adjust speed and incline of the 
treadmill to target specific levels of effort as assessed by HR. Exercise intensity was pre-set at 
the high-moderate level, which was determined by the standard calculation (70% of HRmax [(220-
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age) * .70]). Supervising staff were responsible for checking the computerized HR feedback 
system every five minutes per-session in order to verifying participants were exercising within 
their target HR zone. Additional elements included the review of session procedures and 
accomplishments at the end of each session. 
Waitlist [WL]. Participants assigned to the WL condition completed assessments at the same 
time intervals as the two active conditions, but did not participate in exercise interventions.  
Data Analysis Strategy 
We performed a repeated-measures ANOVA using mixed-effects models (MRMs) in 
SPSS 21.0. The MRM approach to repeated measures ANOVA is advantageous because it 
allows inclusion of all participants regardless of missing data (which improves power and 
generalizability), can model the covariance matrix of the repeated measures more flexibly than 
ANCOVA, and is the recommended method for longitudinal data analysis (Hamer & Simpson, 
2009). The independent variables in our 2 x 2 x 4 mixed-effects ANOVA were Gender, 
Treatment Condition (EX vs. WL), and Time (pre-treatment, mid-treatment, post-treatment, and 
the three week follow-up). We treated Time as a categorical variable in an ANOVA model rather 
than as a continuous variable in a growth curve model because it allows the change over time to 
be free of constraints that would be required in a functional growth curve model. This approach 
is recommended when one performs multiple between-group comparisons over a small number 
of assessment points (Blackwell, Mendes De Leon, & Miller, 2006).  
Pattern mixture modeling (Hedeker & Gibbons, 2006) was used to test the effects of 
missing data on the model. In pattern mixture modeling one investigates whether missing data 
patterns moderate the results. Accordingly, we created a variable coding each participant’s 
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dropout status (i.e., identifying each participant as either a dropout [coded 1] or completer [coded 
0]). This variable was then entered as a moderator of the effects in our model (Hedeker & 
Gibbons, 2006). Analyses included all randomized individuals (N = 60; 45 Female1).  
Results 
 
Baseline Equivalence and Attrition 
As can be seen in Table 1.1 below, the study conditions (EX [n = 40], WL [n = 20]) did 
not differ on any demographic or clinical (i.e., ASI) measures at pre-treatment, suggesting that 
random assignment produced groups with comparable demographic and clinical characteristics 
(Smits et al., 2008). Further, a one-way ANOVA revealed that pre-treatment ASI scores did not 
vary as a function of Gender (F(1,58) = .18, p = .67). One-way ANOVAs also indicated neither 
mean participant age (F(1,58) = .71, p = .40) or mean pre-treatment ASI (F(1,58) = .66, p = .42) 
differed significantly between the two study sites. Our study had a dropout rate of 21.7% (n=13; 
10 in EX and 3 in WL), although all participants were included in the mixed effects analysis. 
Chi-square analyses revealed that there was not a significant difference between study condition 
(c2(1) = .78, p = .51), gender (c2(1) = .33, p = .56), or study site (c2(1) = .29, p = .59) in dropout 
rate. Lastly, a one-way ANOVA revealed that there was no difference between dropouts and 
completers, F(1,58) = .92, p = .34, on pre-treatment ASI scores.  
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 Exercise Condition 
(N = 40) 
 Waitlist Condition  
(N = 20) 
Variable M SD  M SD 
Age 19.7 2.3  22.7 9.4 
ASI 33.0 6.4  34.6 6.6 
ASI by Gender      
     Male 31.0 5.7  35.0 8.4 
     Female 33.4 6.5  34.3 5.8 
  
n 
 
% 
  
n 
 
% 
Gender      
     Male 8 20.0  7 35.0 
     Female 32 80.0  13 65.0 
Race      
     White 20 50.0  16 80.0 
     African American 4 10.0  0 0.0 
     Asian  3 7.5  0 0.0 
     Other 2 5.0  1 0.0 
     Missing/Not reported 11 27.5  3 15.0 
Hispanic or Latino ethnicity 2 5.0  1 5.0 
TABLE 1.1 BASELINE CHARACTERISTICS 
Hypothesis Testing 
 
Pattern mixture modeling was used to test the effects of dropout status on outcome (ASI). 
Results showed the dropout variables did not affect outcome (i.e., p ≥ .20 for all dropout main 
effects and interactions). Thus, dropout variables and their interactions were removed from the 
final model. In our final model, we observed a significant main effect for Time, F(3,87) = 50.21, 
p = .000, and Treatment Condition, F(1,55) = 46.19, p = .000, indicating a general improvement 
over time and lower scores in EX vs. WL, respectively. These main effects were qualified by a 
significant Time x Treatment Condition interaction, F(3,87) = 20.67, p = .000, suggesting greater 
improvement in AS for those in EX compared to WL. Additionally, we found a significant 
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Gender x Treatment Condition interaction, F(1,55) = 4.53, p = .04, such that, collapsed across 
time points, in EX compared to WL, men evidenced lower mean ASI than women. 
Finally, consistent with our hypothesis, we observed a significant Time x Treatment 
Condition x Gender interaction, F(3,87) = 3.37, p = .02, such that the relative improvement over 
Time in EX compared to WL was different for males than for females (see Figure 1.1). To 
further understand this three-way interaction, we decomposed the Time variable, which consisted 
of 4 levels (hence 3 degrees of freedom), into three simple contrasts: the change from pre- to 
mid-treatment, from pre- to post-treatment, and from pre to follow up.  
We then investigated whether these contrasts interacted with Treatment Condition and 
Gender. These analyses showed that the change from pre- and mid-treatment interacted with 
Treatment Condition and Gender, b = -11.61, t(125) = -2.99, p =.003, such that the relative 
improvement in Exercise compared to WL was greater for men than for women (see Figure 1.1). 
The other two contrasts (pre-to-post and pre-to-follow-up changes) were not moderated by 
Treatment Condition and Gender (p’s ≥ .30), contrary to our prediction. In particular, the lack of 
a significant Treatment Condition x Gender x pre- to post-treatment contrast (b = -3.56, t(98) = -
.80, p =.43) suggests that, at post-treatment, the overall improvement in EX vs. WL in response 
to an exercise intervention was not different for men and women. 
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Note, AS Reduction is depicted as a function of the interaction between gender and exercise self-
reported levels of as measured using the anxiety sensitivity index (ASI) assessed at four time 
points—pre-intervention (pre), mid-intervention week 1 (mid), post-intervention week 2 (post), 
and at 2 weeks following the intervention (follow-up). 
FIGURE 1.1. ANXIETY SENSITIVITY (AS) REDUCTION OVER TIME 
Discussion 
Overall, our findings add to the growing body of literature indicating that the effects of 
exercise on anxiety-related constructs may be stronger for males than for females. Additionally, 
our study expands previous work by finding that gender also moderates the effects of a brief 
exercise intervention on AS, an anxiety vulnerability trait. Specifically, our findings 
demonstrated that two weeks of moderate intensity exercise can effectively reduce ASI across 
gender. However, as indicated by a significant gender by time by treatment condition interaction, 
the relative improvement over time in EX compared to WL was different for males than for 
females. This was driven by greater relative ASI reduction for men between pre- and mid-
0
5
10
15
20
25
30
35
40
pre mid post follow-up
AS
I Women [EX]
Men [EX]
Women [WL]
Men [WL]
 31 
treatment. Despite their more-robust early treatment gains, however, men did not show greater 
relative improvements in EX compared WL than women at post-treatment nor at follow-up.  
Although speculative, we offer one potential mechanism accounting for greater AS 
reductions observed in men relative to women over the first week of exercise that can be drawn 
from the broader AS and exercise physiology literature. Namely, gender differences in 
physiological response to exercise appear to contribute to differing degrees of comfort during, 
and in-response-to, exercise performance. Specifically, women exhibit differential metabolic, 
pulmonary, and cardiovascular patterns compared to men of comparable fitness, including 
greater indices of physiological stress and autonomic arousal (Harms et al., 1998; Harms 2006; 
Tarnopolsky et al., 1990; Spina et al., 1993). For example, during moderate-intensity long-
duration exercise, while males utilize lipids and metabolize carbohydrates more efficiently than 
females, females exhibit lower insulin and higher epinephrine concentrations (Tarnopolsky et al., 
1990). Indeed, these data parallel women’s reporting greater stress and exhaustion following 
exercise (Gavin, Sequin, & McBrearty, 2006). This suggests a potential for more aversive 
somatic responses to exercise in women, which among inactive women with elevated AS, is 
likely to be particularly pronounced within the beginning stage of initiating an exercise regimen.  
A number of limitations deserve mention. First, although individuals with elevated AS 
are at risk for clinical anxiety disorders, our use of a relatively small sample of young at-risk 
students, as opposed to a large treatment-seeking sample, limits the generalizability of our 
results. For example, we cannot infer that the effects of exercise on AS is moderated by gender 
in older or clinical anxiety-disordered samples. The small number of males in our sample also 
limits generalizability and reduces our power to detect gender differences. However, a post-hoc 
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Monte Carlo study suggests that we have sufficient power (greater than .80) to a detect medium 
effect size for our gender x study condition x pre- to post-treatment (and pre- to follow-up) 
interactions. Replication of gender differences in AS reduction in response to aerobic exercise by 
future studies must be evidenced before firm conclusions can be drawn.  
 As another limitation, our intervention was only two weeks in length and was compared 
only to a waitlist control condition. Further, because we did not assess exercise continuation of 
participants after the assessment period, we cannot speak to gender differences in response to 
long-term exercise. Additionally, evaluating the effects of aerobic exercise on rates of AS 
relative to other brief active control conditions (e.g., strength training, mind-body exercise, 
health education course) may yield differing between-gender comparisons. Though we speculate 
the smaller AS-reduction observed in women by the end of the first week of exercise to reflect 
elevated perceived distress relative to men, we cannot confirm this with the given data. Though 
participants were cued by experimenters to provide subjective distress ratings during exercise, 
this procedure was intended solely as a clinical exposure technique (i.e., attention manipulation); 
in future studies, such ratings should be formally recorded to evaluate their role in the 
effectiveness of exercise. 
In conclusion, our findings point to the possibility that responses to exercise interventions 
for anxiety pathology vary by gender. This may have implications for the delivery of these 
interventions and highlight the possibility that the mechanisms of change of exercise 
interventions, at least as it relates to anxiety reduction, may be different in women than men. We 
hope that this finding encourages further research aimed at understanding differences between 
men and women in terms of their responding to exercise interventions. In addition to considering 
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mechanisms at multiple levels (e.g., psychological, physiological), studies that compare types of 
exercise modalities (e.g., yoga, resistance training) and doses (e.g., intensities, frequencies, and 
duration) may yield findings that can help refine the knowledge needed to develop individually 
tailored exercise interventions.  
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STUDY 2 - The Effects of a Hatha Yoga Intervention on Facets of Distress 
Tolerance 
Individuals with low distress or affective tolerance experience negative emotions as 
particularly threatening and are highly motivated to alter such experiential states (Simons & 
Gaher, 2005). As a result of their intolerance of distress, these individuals tend to engage in 
coping strategies that pose mental and physical health risks, such as cigarette smoking (Brown, 
Lejuez, Kahler, Strong, & Zvolensky, 2005; Buckner, Keough, & Schmidt, 2007; Bujarski, 
Norberg, & Copeland, 2012), and binge eating and purging (Anestis, Selby, Fink, & Joiner, 
2007), as a means to reduce or avoid emotional distress. Accordingly, distress intolerance has 
been implicated as a transdiagnostic risk and maintenance factor for psychopathology 
(Zvolensky, Bernstein, & Vujanovic, 2011), particularly in disorders characterized by heightened 
emotional reactivity and avoidance, such as substance use, anxiety, eating, and personality 
disorders (Leyro, Zvolensky, & Bernstein, 2010; Zvolensky et al., 2011).  
Extant research has conceptualized and approached measurement of affective intolerance 
in diverse ways and among heterogeneous samples (Bernstein, Zvolensky, Vujanovic, & Moos, 
2009; McHugh & Otto, 2012). This has resulted in the emergence of various domain-specific 
affective intolerance sub-constructs that can be challenging to integrate (Bernstein et al., 2009). 
 
 
_____________________ 
Study published in peer reviewed journal. Medina, J. L., Hopkins, L. B., Powers, M. B., Baird, S. O., & 
Smits, J. A. J. (2015). The effects of a hatha yoga intervention on facets of distress tolerance. Cognitive 
Behaviour Therapy, 44, 288-300. I served as primary author involved in the study design, data analysis 
and manuscript writing.
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 For example, “intolerance of uncertainty,” particularly relevant to pathology of generalized 
anxiety (Dugas, Buhr, & Ladouceur, 2004) and obsessive-compulsive disorders (Holaway, 
Heimberg, & Coles, 2006; Tolin, Abramowitz, Brigidi, & Foa, 2003), reflects a cognitive-
affective intolerance for uncertain outcomes. In comparison, “discomfort intolerance” (DI; 
Schmidt, Richey, & Fitzpatrick, 2006) and “anxiety sensitivity” (AS; Maller & Reiss, 1992) 
include aversion to somatic sensations of autonomic arousal, which are cornerstone to panic 
disorder psychopathology. 
 Deviating from a specific distress domain in their operationalization of the construct, 
Simons & Gaher (2005) define “distress tolerance” (DT) by facets involved in the process of 
managing and regulating subjective emotional distress. These include: (1) one’s general 
perceived Tolerance of negative or threatening emotions, (2) one’s Appraisal or value judgment 
about feeling distressed or upset, as well as (3) the resulting Absorption of attention in the 
distress itself, and (3) the propensity for action aimed at Regulation or reduction of distress 
(Simons & Gaher, 2005). In support of this conceptualization, scores on the self-report based 
Distress Tolerance Scale (DTS; Simons & Gaher, 2005) have predicted symptom severity and 
problem behavior in a range of clinical populations (Anestis et al., 2007; Leyro et al., 2010).  
Studies examining the psychometric properties of various affective intolerance 
assessments also evidence support for the existence of a common, domain-general emotional 
intolerance construct. For example, a factor analysis (McHugh & Otto, 2012) of different self-
report assessments of the construct yielded a single-factor latent structure of affective intolerance 
captured by the Discomfort Intolerance Scale (Schmidt et al., 2006), Anxiety Sensitivity Index 
(Reiss, Peterson, Gursky, & McNally, 1986), and DTS (Simons & Gaher, 2005). The authors 
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concluded that these measures likely tap a common underlying core trait of affective intolerance, 
which is most-directly assessed by the DTS (McHugh & Otto, 2012). Thus, distress tolerance 
DT, as measured by the DTS, appears to be a good option for investigations examining the 
relationship of affect intolerance to psychopathology and intervention effects.  
Because DT is a pervasive contributor to psychopathology, several existing evidence-
based treatments specifically aim to target DT. Promisingly, initial intervention research 
demonstrates that DT can be enhanced and that increases in DT correspond to improvements in 
symptom severity (Brown et al., 2008; Leyro et al., 2010). These interventions have typically 
taken a mindfulness-based and/or exposure-based, cognitive-behavioral approach. Dialectical 
behavior therapy (Linehan, 1993), for example, is an integrative approach that includes a DT 
skills training component for reducing emotional reactivity, and it has shown efficacy for treating 
borderline personality (Linehan, 1993; Linehan, 1987; Neacsiu, Rizvi, & Linehan, 2010), eating 
pathology (Telch, Stewart, & Linehan, 2001; Telch et al., 2001), and substance use disorders 
(Dimeff & Linehan, 2008). Brown and colleagues have recently developed a novel, combined 
mindful acceptance/CBT intervention targeting DT for smoking cessation in adults who have 
previously failed cessation attempts (Brown et al., 2008). By enhancing resilience to distress 
during critical early abstinence periods, such as the withdrawal phase, this treatment has shown 
efficacy for difficult-to-treat smokers (Brown et al., 2013).  
 The mind-body practice of yoga, which is conceptually akin to the interventions just 
described, may hold similar promise for enhancing DT. Hatha yoga is a branch of yoga described 
as “moving meditation,” a physical practice of yoga (Iyengar & Menuhin, 1995). Hatha yoga 
requires one to focus attention on interoceptive cues and breath (pranayama) during and while 
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transitioning to challenging, potentially uncomfortable physical postures called asanas (Hewitt, 
1990; Iyengar & Menuhin, 1995). From the Eastern philosophical tradition of mindfulness, hatha 
yoga encourages one to implement present-centered awareness, non-reaction, and non-
judgmental acceptance of one’s present state despite physical or psychological discomfort. In 
combination with promotion of mindful awareness and acceptance, hatha yoga, especially when 
practiced at moderate to vigorous intensities, may promote habituation to distress in low-DT 
persons. Indeed, exposure-based methods of behavioral therapy, including programmed aerobic 
exercise interventions, have proved effective for reducing sensitivity to autonomic arousal in 
anxious populations (Broman-Fulks & Storey, 2008; Smits et al., 2008).  
 Furthermore, evidence from a number of sources has accumulated for the beneficial 
effects of yoga on mental health problems, including anxiety (Dunn, 2009; Kirkwood, Rampes, 
Tuffrey, Richardson, & Pilkington, 2005; Smith, Hancock, Blake-Mortimer, & Eckert, 2007), 
depression (Shapiro et al., 2007; Uebelacker et al., 2010), disordered eating (Carei, Fyfe-
Johnson, Breuner, & Brown, 2010; McIver, O’Halloran, & McGartland, 2009), and 
psychological distress secondary to medical conditions (Curtis, Osadchuk, & Katz, 2011; 
Shapiro et al., 2007). Yoga also has received support for reducing perceived stress and enhancing 
overall well-being in sub-clinical populations (Brisbon & Lowery, 2011; Granath, Ingvarsson, 
von Thiele, & Lundberg, 2006; Huang, Chien, & Chung, 2013; Smith et al., 2007; Uebelacker et 
al., 2010).  
 Despite the promise for improving psychological health in distress-sensitive persons, 
there have been no published reports of the efficacy of yoga for increasing DT. In addition to the 
theoretical promise of using yoga to improve DT, the importance of this research is further 
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underscored by the increasing popularity of yoga in Western culture as an alternative approach to 
stress management and psychological wellbeing (Barnes, Bloom, & Nahin, 2008). The positive 
reputation of yoga only enhances its potential to become an acceptable and accessible 
intervention for many people.  
In this study, we test the hypothesis that practicing hatha yoga can increase DT. This 
hypothesis was tested using data collected as part of a larger investigation examining the 
feasibility, acceptability, and efficacy of a hatha yoga intervention for targeting physiological 
stress reactivity in women high in affective eating and risk for obesity (Hopkins-DeBoer, 
Medina, Baird, & Smits, 2016). The parent trial draws rationale for testing its hypothesis from 
the obesity and eating disorder literatures, which describe emotional or stress-induced eating as a 
major contributor to clinically diagnosable eating disorders, such as binge eating disorder, as 
well as to rates of obesity, particularly among females (Adam & Epel, 2007). The need to 
enhance affective coping capacity in this population provides rationale for the present 
investigation’s examination of DT as an avenue by which yoga may reduce disordered eating 
behavior.  
Accordingly, under this parent study, we randomized 52 females at risk for eating 
disorders and obesity to either an 8-week hatha yoga intervention (YOGA) or a waitlist control 
condition (WL). Self-reported emotional eating and DT were measured at baseline, weekly 
during treatment, and 1-week post-treatment. Our second aim was to examine increases in DT as 
a mechanism of change accounting for reduced behavioral symptoms of psychopathology  
resulting from the yoga intervention. Given the sample recruited for the parent study, we 
examined increases in DT as a mediator of the intervention effects on emotional eating. We 
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hypothesized that, relative to waitlist participants, those in the yoga condition would report 
greater increases in DT over the course of the intervention, and that these increases in DT would 
mediate the effects of yoga on emotional eating.  
 
Method 
Participants 
Participants included adult females from the Dallas community who reported elevated 
levels of perceived stress, emotional eating, and dietary restraint. Eligibility criteria included 
score of ≥ 2.06 on the emotional eating subscale (DEES) of the Dutch Eating Behavior 
Questionnaire (DEBQ; van Strien, Frijters, Bergers, & Defares, 1986), score of ≥ 15 on the 
Restraint Scale (Polivy, Herman, & Howard, 1988), and elevated perceived stress, as defined by 
scoring ≥ 0.50 SD above the community mean on the Perceived Stress Questionnaire (Levenstein 
et al., 1993). Eligibility also required sufficient command of the English language and providing 
written physician medical clearance to participate in yoga practice.  
Exclusion criteria included: having regularly practiced (i.e., once a week or more) yoga 
or other mind-body practices (e.g., tai chi, meditation) within the last year; a significant change 
to physical activity pattern in the past 3 months; current severe depression or substance 
dependence; lifetime history of anorexia nervosa or severe mental illness (i.e., bipolar or 
psychotic disorder of any type); pregnancy; medical conditions that could be aggravated by 
yoga; body mass index ≥ 40; cognitive dysfunctions or organic brain syndrome that could 
interfere with capacity to perform study protocol; receiving inpatient psychiatric hospitalization 
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within the past year; or receiving concurrent psychiatric treatment, including both psychotherapy 
and psychotropic medication. 
Procedures 
Participants will be recruited through advertisements in local newspapers and flyers that 
included a link to a secured online eligibility prescreen survey. Respondents who appeared 
eligible based on their prescreen will be scheduled for a baseline visit one week prior to the start 
of the yoga program. During this visit participants will be randomized to one of the two 
conditions (YOGA or WL) using a computerized random number generator. Participants will 
then be oriented to the program (depending on condition assignment) and scheduled to come 
Those randomized to the yoga condition were asked to attend twice-weekly, 90-minute 
Bikram yoga-style classes at a local yoga studio. Each session consisted of the same series of 26 
hatha yoga postures, two breathing exercises, and two savasanas (i.e., a resting/relaxation 
posture), in a room heated to 104 degrees Fahrenheit, which aids in safe muscle stretching. We 
selected this type of yoga because it is considered suitable for practitioners of various physical 
capabilities and, due to its consistent series of postures, is ideal for a standardized intervention 
protocol. In addition, the hot temperature would provide an opportunity to learn to become 
confortable with the bodily sensations associated with heat exposure (i.e., increase tolerance of 
physical distress). At the end of each week of the intervention period, as well as at post-
intervention (week 9), all participants (both those assigned to YOGA and WL) were prompted by 
email to complete a 15-20 minute online survey containing self-report measures of DT, 
emotional eating, stress, and mood. Following their completion of the week 9 assessment, WL 
participants were provided the equivalent 2-month yoga membership at no cost. 
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Measures 
Distress tolerance. The Distress Tolerance Scale (DTS; Simons & Gaher, 2005) is a 15-
item self-report scale measuring four facets involved in the expectation of, evaluation of, and 
reaction to distressing states. In addition to a total DT score, the DTS produces four subscale 
scores measuring: (1) distress Tolerance (i.e., perceived tolerability and aversiveness of 
distressing feelings; e.g., “I can’t handle feeling distressed or upset”); (2) Appraisal of distress 
(i.e., acceptability of having the distress; e.g., “My feelings of distress are not acceptable”); (3) 
Absorption (i.e., tendency for distress to disrupt attention and interfere with in-the-moment 
functioning; e.g., “My feelings of distress are so intense that they completely take over”); and (4) 
Regulation (i.e., the strength of one’s propensity to immediately avoid or attenuate the distress; 
e.g., “I’ll do anything to avoid feeling distressed or upset”). Participants responded to items on a 
5-point Likert-type scale, with ratings ranging from strongly agree (1) to strongly disagree (5). 
The DTS has exhibited 6-month temporal stability and internal consistency, evidencing good 
reliability (Simons & Gaher, 2005). Total DTS scores, as well as each of its subscales have 
demonstrated adequate construct validity (Bernstein et al., 2009; Leyro, Bernstein, Vujanovic, 
McLeish, & Zvolensky, 2011; Simons & Gaher, 2005). In the present sample, internal 
consistency (Chronbach’s alpha) for the DTS total score at baseline was 0.87. Alpha coefficient 
for the DTS subscales, Tolerance, Absorption, Appraisal, and Regulation were .72, .77, .72, and 
.70, respectively. 
 Emotional eating. The Dutch Eating Behavior Questionnaire (DEBQ; van Strien, Frijters, 
Bergers, & Defares, 1986) is a widely used and validated 33-item measure that assesses 
restrained eating, emotional eating, and eating in response to external cues (van Strien, Frijters, 
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van Staveren, Defares, & Deurenberg, 1986). Each item is rated on a 5-point scale from 1 (never) 
to 5 (very often). The emotional eating scale (DEES) of the DEBQ, which measures tendency to 
eat in response to negative emotions, was used to screen for emotional eating, with a score ≥ 2.06 
indicative of significantly elevated distress-induced eating tendencies. In the present sample, 
internal consistency (Chronbach’s alpha) for the DEES at baseline was 0.92. 
Data Analytic Strategy 
In order to analyze changes in self-reported DT and emotional eating assessed over the 
intervention period, we used mixed effects multilevel modeling (MLM) in SPSS® Version 20, 
which allows for the analysis of longitudinal data both within and between subjects (S. 
Raudenbush, Bryk, Cheong, & Congdon, 2004; Singer & Willet, 2003). MLM has several 
advantages over other strategies commonly used to analyze longitudinal data (MacKinnon, 2008; 
Singer & Willet, 2003; Zhang, Zyphur, & Preacher, 2009). For example, as a form of intent to 
treat analysis (ITT), MLM allows for the inclusion of subjects with missing data, whereby it is 
able to estimate a longitudinal change trajectory for each subject using the number of completed 
assessments available. Additionally, MLM allows for modeling of the error covariance within-
subjects, which was modeled as autoregressive [AR(1)] in the present study. 
In line with standard guidelines for MLM (Singer & Willet, 2003), we tested a series of 
2-level models to measure rates of improvement (Level 1) in self-reported levels of distress 
tolerance (DTS) and emotional eating (DEES) as a function of study condition (Level 2). Level 1 
of the MLM model estimates outcome as a function of time within individual (i.e., Outcomeij = 
b0i + b1i * Timeij +eij, where i represents each individual subject and j represents each 
assessment point). Level 2 of the model allows for between-individual characteristics (i.e., study 
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condition [COND], coded “0 = Yoga”, “1 = WL”) to influence outcome. The equations for Level 
2 are b0i = 00 + 01*CONDi + u0i, and b1i = 10 + 01*CONDi + u1i. Level 2 is nested into the 
Level 1 equation, forming a composite 2-level model with the equation, Outcomeij = g00 + 
g10*Time + g01* COND + g11* COND *Time + (eij + u0i + u1i*TIME).  
 In order to determine the most accurate MLM model reflective of changes over time in 
our main outcomes (DTS, DEES), we compared linear, quadratic, and logarithmic growth curves 
for each outcome based on their deviance statistics (Bayesian Information Criterion [BIC]). For 
both DTS and DEES outcomes, the logarithmic growth curve was found to be the best fit to the 
data. Therefore, the logarithmic transformation of time [ln(Time)] was used in all tests analyzing 
these measures longitudinally.  
Guidelines for estimating power to detect polynomial change using MLM in longitudinal 
studies have been published by Raudenbush and Xiao-Feng (2001), taking into account study 
duration, assessment frequency, and sample size. For our purpose of measuring weekly change in 
our outcomes over a 10-week period, a sample of N ≥ 44 was predicted to be adequate for 
achieving ≥ 80% power to be able to detect a large effect (Raudenbush & Xiao-Feng, 2001).  
 Mediation analyses. Establishing mediation in randomized trials requires demonstrating 
that the change in the mediator causes a change in the outcome. Enhancing the causal 
interpretation of our mediation test, we used a multi-level (MLM) cross-lagged panel analysis to 
test the mediating effect of DTS on subsequent reductions in DEES (Kraemer, Stice, Kazdin, 
Offord, & Kupfer, 2001; Kraemer, Wilson, Fairburn, & Agras, 2002). To test the size and 
significance of the proposed mediator, DTS, we employed MacKinnon and colleagues’ 
asymmetric distribution of products test (Fritz & MacKinnon, 2007; MacKinnon, Fairchild, & 
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Fritz, 2007; MacKinnon, Lockwood, Hoffman, West, & Sheets, 2002). Significance of a 
proposed indirect mediated pathway is determined based on confidence intervals for the product 
of the indirect paths of coefficients A*B. If the 95% confidence interval for the A*B product 
does not include 0, the mediated effect is considered significant (MacKinnon et al., 2004). The 
coefficient for the interaction term (i.e., COND*Time effect on DTSj) represents the A Path of 
our model (labeled A3 in Figure 2.2). In order to control for temporal order of effects between 
mediator and outcome using a cross-lagged panel strategy, we lag-transformed the original 
variable DEES by one time point (DEESj+1). Thus, the B Path of our mediation model represents 
the coefficient for the effect of DTS j on DEES j+1 controlling for DEESj (i.e., levels of the 
mediator DTS predicting future levels of the outcome DEES; see Figure 2.2).  
 Size of the mediated effect. In order to estimate the proportion mediated by the proposed 
mediator (PM; Shrout & Bolger, 2002), an effect size was calculated using the formula (A3* 
B)/C. The PM represents the proportion of the total effect of the hatha yoga intervention on 
emotional eating (i.e., the C Path) that was mediated by distress tolerance.  
Results 
Sample Characteristics 
We aimed to recruit a sample of women at-risk for obesity due to high levels of 
emotional/stress-induced eating. Out of 650 individuals who filled out the online prescreen 
survey of demographics, eating behavior, perceived stress, depression, and body mass index 
(BMI), 573 did not meet initial eligibility criteria, and 25 declined participation. Seventy-three of 
the remaining women completed the diagnostic screening visit. Fifty-two eligible women 
attended the baseline orientation visit, where 27 were randomized to YOGA and 25 to WL.  
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Our final sample of 52 women (M age = 33.52, SD = 6.43) had an average BMI within 
the overweight range at baseline. Prescreen emotional eating (DEES) scores for those 
randomized were approximately 2 SDs above normative scores for both obese and non-obese 
women (Ouwens, van Strien, & van der Staak, 2003; van Strien, Frijters, Bergers, et al., 1986; 
van Strien & Ouwens, 2003). The sample consisted primarily of non-Hispanic White participants 
(75%, n = 39). Ten (19.2%) of participants identified as Hispanic/Latina. Participants were well-
educated and predominantly middle to upper-middle class with 60% reporting an annual 
household income of below $75,000. All but one participant reported receiving either a college 
degree or some college, and 100% reported completing high school. See Table 1 for specific 
baseline descriptive statistics. 
The study conditions did not differ at baseline on BMI, race/ethnicity, or annual income, 
nor were there differences in baseline assessments of DTS or DEES (p’s > .14). Conditions 
differed by age, with the YOGA group being significantly younger (F(1,50) = 5.96, p = .02). We 
therefore controlled for age in all analyses. Overall, 17% (n = 9) of our sample dropped out of 
the intervention (i.e., missed both post-treatment laboratory visit and survey). Seven (26%) 
YOGA participants dropped out, whereas only two (8%) WL participants dropped out. However, 
chi-square analyses revealed that attrition did not differ significantly between conditions (c2 = 
2.91, p = .09). Study completers did not differ from the 10 dropouts in baseline levels of BMI, 
age, or DEES and DTS scores.  
Average weekly yoga attendance for the 27 participants randomized to yoga ranged from 
0.13 to 3.25 sessions per week (M = 1.56, SD = 0.82). Ten (27%) participants met (n = 3) or 
exceeded (n = 7) the prescribed two classes per week. On average, yoga participants completed 
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60% of the 16 prescribed yoga sessions, and sixteen (84%) completed at least 75% (12 of 16 
classes) of the intervention.  
 
 
 
      Yoga     (N = 27) 
Waitlist 
(N = 25) 
Total 
(N = 52) 
Variable    M         SD             M        SD M        SD 
Age 
BMI 
31.52        5.47 
28.38        4.08 
           35.68      6.80 
           26.60      5.94 
          33.60      6.09 
          27.4        5.09 
DTS 3.22         0.68             3.30       0.85           3.26        0.75 
DEES 3.60         0.81             3.44       0.68           3.52        0.74 
TABLE 2.1. BASELINE CLINICAL AND DEMOGRAPHIC CHARACTERISTICS 
  
Variable Name 1 2 3 4 5 6 7 8 9 
1. DTS Total  - .86** .85** .80** .78**   .39** 
 -
.40** -.02 -.05 
2. DTS Tolerance - - .70** .60** .53** .36 
 -
.47** -.15 -.08 
3. DTS Absorption - - - .57**  .47**   .49** 
 -
.40**  .02  .00 
4. DTS Appraisal - - - - .56**  .32* -.24  .14  .04 
5. DTS Regulation  - - - - - .10 -.17 -.04 -.16 
6. FFMQ  - - - - - - 
 -
.41**  .03 -.16 
7. DEES - - - - - - -  .03  .11 
8. BMI - - - - - - - -  .26 
9. Condition - - - - - - - - - 
          
Note. * p < .05; ** p < .0 
TABLE 2.2. DESCRIPTIVE DATA AND ZERO-ORDER RELATIONS AMONG 
PREDICTOR AND CRITERION VARIABLES 
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Hypothesis Testing 
 Intervention effects on distress tolerance. As hypothesized, the Condition-by-Time 
interaction was significant (b = -0.168, t(128) = -2.014, p = 0.046), revealing that the loglinear 
rate of increase in DT was significantly greater in YOGA than WL (Figure 2.1). We calculated a 
Cohen’s d effect size for the between-group effect using the approach recommended by 
Raudenbush and Xiao-Feng (2001) in multilevel mixed effects models. This yielded a 
standardized effect size (Cohen’s d) of .82, suggesting that the between-group effect on slope of 
improvement in DTS was large. This suggests that the average YOGA-treated participant fared 
better than 79% of those in WL on DT enhancement. 
 
FIGURE 2.1. CHANGES IN DISTRESS TOLERANCE LEVELS (DISTRESS TOLERANCE 
SCALE - DTS) OVER TIME (PRE-TO-POST INTERVENTION) BY STUDY 
CONDITION. 
 Intervention effects on DTS subscales. Additional analyses were conducted to examine 
between-group differences in the slopes of change for each of the DTS subscales (i.e., Tolerance, 
Appraisal, Absorption, and/or Regulation). When testing the same model for each of the four 
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subscales, between-group differences were present for Tolerance (b = 0.226, t(149) = 2.154, p = 
.033; d = .89) and Absorption (b = 0.260, t(136) = 2.544, p = .012; d = .97), but not for Appraisal 
(b = 0.076, t(139) = 0.977, p = .330) or Regulation (b = 0.107, t(120) = 0.918, p = .361).  
 Intervention effects on emotional eating. As hypothesized, there was a significant 
Condition-by-Time interaction on DEES (b = 0.218, t(104) = 2.519, p = .013), suggesting that 
the rate of loglinear reduction in emotional eating was greater for YOGA than WL (Figure 2.3). 
This effect was large (Cohen’s d = .92), indicating that the average YOGA participant fared 
better than 82% of those in WL on emotional eating.  
 
FIGURE 2.2. CHANGES IN EMOTIONAL EATING (DEES) OVER TIME BY CONDITION. 
Mediation. The 95% confidence interval for the mediated effect for DTS score was (-
.025, .002). Thus, mediation was not supported for the DTS total score (see Figure 2.2 for A3 
and B path coefficients). We replicated these analyses using the DTS subscales. These analyses 
yielded no mediation for any of the subscales except for DTS-Absorption (95% confidence 
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interval for the mediated effect of (-.07, .01); see Figure 2.4 for A3 and B path coefficients). 
Percent of the effect of hatha yoga on emotional eating mediated by DTS-Absorption was 15%. 
 
 
 
 
FIGURE 2.3. CROSS-LAGGED MEDIATION MODEL FOR DTS. 
 
 
FIGURE 2.4. CROSS-LAGGED MEDIATION MODEL FOR DTS-ABSORPTION. 
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Discussion 
 The primary aim of this study was to test the effects of an 8-week hatha yoga intervention 
on DT. This investigation was conducted as a secondary aim of its parent trial examining a hatha 
yoga intervention for physiological stress reactivity and affective eating, a risk factor for 
disordered eating and obesity. Results showed that, in comparison to a WL control group, an 
intervention involving twice-weekly hot hatha (Bikram) yoga for 8 weeks resulted in greater 
improvements in DT (as measured by the DTS) and greater reductions in emotional eating (as 
measured by the DEES subscale of the DEBQ). Indeed, by week 9 post-intervention assessment, 
yoga had produced large and clinically meaningful effects, proving to be approximately 80% 
more effective than WL for improving both DT and emotional eating.  
 The yoga intervention’s effect on self-reported DT is consistent with results from 
previous studies showing increases DT resulting from mindfulness and exposure-based 
behavioral interventions (Baer, 2009; Brown et al., 2008). Our findings for DT suggest potential 
for yoga interventions to improve affective tolerance in a host of psychological disorders. In 
addition, our finding that yoga also reduced emotional eating echoes findings from previous 
studies that provided initial support of yoga in the treatment of eating disorder symptoms (Carei 
et al., 2010; McIver et al., 2009). Moreover, we expanded on the results of these previous trials 
by demonstrating efficacy of yoga for treating subclinical disordered eating problems and related 
distress, suggesting its clinical utility as a prevention strategy for females at-risk for future 
obesity and other adverse health effects caused by dysregulated eating patterns.  
Our finding that yoga directly enhanced DTS subscales, Tolerance (i.e., meta-cognitions 
about capacity to handle distress) and Absorption (i.e., attentional interference during distress), 
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suggests that 8 weeks of Bikram yoga practice particularly impacted cognitive components 
involved in distress processing, rather than those involved in emotional and behavioral distress 
reactivity (i.e., Appraisal or Regulation). That we found significant between-condition effects 
over time on these subscales is also consistent with previous studies showing that regular mind-
body practice is associated with enhanced capacity to sustain attention while completing a task. 
One study found that experienced practitioners of yogic meditation performed better on cognitive 
tasks of attention than non-meditators (Prakash et al., 2010). Another showed that brief 
mindfulness training beneficially modified attention among alcohol dependent persons with no 
previous background in mindfulness (Garland, Gaylord, Boettiger, & Howard, 2010).   
As our second aim, we examined increased DT as a mechanism underlying the effects of 
yoga on a relevant mental health outcome, namely improvements in emotional eating. Results of 
the mediation analyses showed that improvements in DTS-Absorption scores mediated the yoga 
intervention’s positive effect on self-reported emotional eating. Improved Absorption explained 
15% of the improvements in emotional eating caused by the yoga intervention. Thus, one way 
yoga reduces emotional eating, at least in this at-risk sample, appears to be by restoring the 
ability to concentrate and think clearly (i.e., enhanced cognitive capacity) during times of 
distress. Although yoga reduced DT in general (i.e., DTS total scores), it is interesting that it was 
only reductions in the Absorption subscale that drove improvements in emotional eating. 
We can offer only speculation concerning the mixed findings among DTS subscales, 
given the paucity of literature providing context in which to interpret our findings. Little 
empirical attention has been paid to the relative clinical relevance and malleability of the 
individual DTS subscales in response to intervention (McHugh & Otto, 2012). One possibility is 
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that each of the DT facets change at different times or at different rates in response to 
intervention. Though our analyses cannot account for this idea, it may be that an 8-week yoga 
intervention can enhance general self-efficacy for handling distress (i.e., perceived Tolerance), 
which, in turn, makes the distress less salient in-the-moment, thus improving one’s ability to 
approach distress with greater cognitive flexibility (i.e., decreased Absorption). Longer 
interventions and additional follow-up assessments should be used in future research to examine 
this hyposthesis.  
The conjecture that yoga enhances one’s ability to shift attention beyond the sensation of 
discomfort, toward other stimuli in the immediate environment, is supported by the mindfulness 
literature (Baer, 2009; Gard et al., 2012; Garland et al., 2010). For example, Garland and 
colleagues found that a mindfulness intervention for alcohol-dependent participants resulted in 
improved ability to shift attention away from visual alcohol cues, as well as decreased reliance 
on thought-suppression strategies, a form of experiential avoidance. Although this study lacked a 
control condition, it provides preliminary support for the use of mindfulness interventions for 
preventing stress-induced alcohol relapse (Garland et al., 2010). We speculate that ultimately, 
with greater capacity to sustain attention mindfully (i.e., reduced distress absorption), individuals 
become able to endure or cope healthfully with distress, rather than turning to food to dampen 
their feelings. Replication and extension of our findings will help more fully explain the 
relationship between yoga, mindfulness, absorption, and emotional eating.  
We would like to note that we only focused on one of several potential psychological 
therapeutic mechanisms (i.e., DT) in this study, and cannot rule out the possibility that changes 
in DT are merely a byproduct of a change in some other perhaps more critical mechanism. Some 
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alternative mechanisms for the effects of yoga may be related to the physiological impact of 
exercise, such as peripheral and/or central nervous system stimulation (Broman-Fulks & Storey, 
2008; Smits et al., 2008; Stoller, Greuel, Cimini, Fowler, & Koomar, 2012) or modulating 
cortisol reactivity to stress (Berger & Owen, 1988; Schell, Ollolio, & Schoneke, 1993). In one 
study, moderate-intensity physical activity, which induces repeated autonomic arousal, was 
negatively associated with frequency of binge eating among individuals who were fearful of such 
autonomic sensations (i.e., high AS, a construct related to DT) and had a tendency to eat as a 
means of coping with negative affect (DeBoer et al., 2012).  
There are several limitations to our study that are worth noting and that can guide future 
investigations. First, our limited sample size and, thus, statistical power may explain our mixed 
findings among DTS subscales. Though power estimates for determining our sample size were 
gathered using published guidelines (Raudenbush & Xiao-Feng, 2001), a greater number of 
participants and/or more-frequent assessments could have enhanced power for detecting 
clinically meaningful condition differences.  
Second, using additional behavioral measures of DT would have corroborated our 
findings using self-reported DTS. Measuring broad DT, or general affect intolerance is difficult 
at this time, however. Current laboratory behavioral measures of DT (e.g., breath holding 
challenge, computerized frustration tasks) tend to tap only domain-specific types of distress (e.g., 
physical discomfort, frustration) and, consequently, have been poorly correlated with each other 
and with other self-report measures (Leyro et al., 2010; McHugh & Otto, 2012). This problem 
calls for development of additional behavioral DT measurement methods that can assess both the 
overarching construct of emotional DT, as in the DTS, as well as its subcomponents.  
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Without the inclusion of additional active study conditions, our study cannot make 
conclusions regarding the comparative effects of yoga to traditional exercise, to psychotherapy, 
or to a contact control intervention. We also cannot ascertain whether yoga is better suited as a 
stand-alone or adjunctive treatment. That is, yoga may best serve as a complimentary 
intervention to established cognitive-behavioral interventions for emotional and binge eating that 
also emphasize broader emotion regulation skills. In short, we are limited in our ability to draw 
conclusions concerning the specificity of the effects of a yoga practice. Attrition represents a 
related limitation, as 25% of the yoga treatment condition prematurely terminated the study. 
Thus, we cannot confirm the effects found here to be a result of intended “dose” of yoga. Future 
studies should assess reasons for yoga dropout and dose underperformance to guide further yoga 
implementation strategies.  
Further research is needed to investigate how and for whom yoga interventions will be 
most useful. It is possible that some groups require integrative treatment strategies to reduce their 
avoidant coping behaviors. One study showed that low DT and poor use of emotion regulation 
strategies were additively predictive of experiential avoidance (McHugh, Reynolds, Leyro, & 
Otto, 2013). This has application to our results, suggesting that enhanced cognitive capacity for 
handling distress (i.e., reduced Absorption) through yoga may be less relevant for emotional 
eaters who do not have available alternative emotion regulation strategies. For these individuals, 
yoga may be more useful as an adjunct to other cognitive and behavioral skills training. 
This study offers preliminary evidence for the benefits of yoga interventions for problems 
characterized by elevated stress and poor affect regulation. First, our findings underscore the 
promise of hatha yoga practice for increasing DT and reducing emotional eating tendencies. 
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Second, our mediation analyses revealed a particular component of the cognitive processing of 
distress – Absorption – mediated the effects of yoga on disordered eating. Interventions that aid 
in affect modulation and enhanced coping are crucial for reducing the public health burden of an 
array of psychological disorders, and this study provides support for further development of 
specialized, mind-body interventions for those low in DT. 
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Study 3 – Biobehavioral Mechanisms Underlying Effects of Yoga on Nicotine 
Withdrawal 
The need for evidence-based clinical intervention for smoking remains a major health 
care priority in the United States (US). As the leading cause of preventable death in the US, 
smoking accounts for the loss of an estimated 480,000 lives each year (United States Department 
of Health and Human Services [USDHHS], 2014). Additionally, an estimated 8.6 million 
individuals live with chronic diseases caused by tobacco use, such as lung cancer, heart disease, 
and COPD (Center for Disease Control [CDC], 2008; Danei et al., 2009). Consequently, at least 
6-8% of total US personal health expenditures can be attributed to caring for these medical 
conditions (Warner, Hodgson, & Carroll, 1999). Importantly, despite increasing development of 
efficacious behavioral and pharmacological smoking cessation interventions (Rigotti, 2001), 
19% of Americans continue to smoke (CDC, 2012). Among daily smokers, rates of heavy 
smoking (i.e., smoking ≥30 cigarettes per day) decreased between 2005 and 2011, while rates of 
light-moderate smoking (1-9 cigarettes per day) significantly increased (CDC, 2012). These rates 
infer the need for more-effective interventions for both groups, while calling particularly for 
strategies to address the increasing trend noted in less severe daily smokers. 
Though 70% of smokers report the intention to quit to their doctors, the vast majority of 
smokers attempt to quit without aid with a less than 10% success rate (Chapman & MacKenzie, 
2010; Fiore et al., 1990). Additionally, established behavioral interventions for smoking 
cessation are associated with high relapse rates (up to 85% within a year) and attrition (Copeland 
et al., 2006; Geraghty et al., 2012; Leeman et al., 2006; MacPherson et al., 2008). In order to 
increase the effectiveness of smoking cessation interventions and reduce the public health impact 
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of smoking, specialized treatments for at-risk smokers may be necessary (USDHHS, 2003). The 
call for the development of specialized interventions for smokers at heightened risk for relapse is 
guided by the selection hypothesis of smoking prevalence, which posits that smokers who are not 
able to quit successfully are “burdened” by specific characteristics that make it more challenging 
to quit (Hughes & Brandon, 2003). The development of specialized interventions is best guided 
by basic experimental research on the putative biobehavioral processes underlying smoking 
relapse in at risk populations.  
Acute symptoms of nicotine withdrawal, which include irritability, frustration or anger; 
anxiety; difficulty concentrating; increased appetite; restlessness; depressed mood; and insomnia 
(DSM-5; APA, 2013), are viewed as a temporary disturbance in internal homeostasis resulting 
from absence or reduction of nicotine. These symptoms, which often cause severe distress and/or 
impairment, either remit when homeostasis is restored in a matter of days or weeks, or can be 
quickly relieved by smoking resumption (Hughes, Higgins, & Bickel, 1994; Hughes, Higgins, & 
Hatsukami, 1990; Shiffman, West, & Gilbert, 2004). Interestingly, there exists considerable 
variability in the nicotine withdrawal-relapse relation (Piasecki, Jorenby, Smith, Fiore, & Baker, 
2003; Weinberger, Desai, & McKee, 2010), suggesting that targeting nicotine withdrawal to 
achieve cessation success may be critical for some but less important for others.  
It has been noted that smokers with comorbid psychopathology in the form of affective 
disorders and SUDs may be more likely than their nicotine-dependent counterparts to experience 
withdrawal more intensely and subsequently relapse during the early quit phase (Weinberger, 
Desai, & McKee, 2010). Theoretically, this may be due to tendencies implicated in these 
conditions related to motivation to escape and avoid negative affect (Baker, Piper, McCarthy, 
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Majeskie, & Fiore, 2004). Research on the affect-vulnerability construct, low distress tolerance 
(DT), may be key to understanding individual difference variability in withdrawal-induced 
relapse (Brown et al., 2001; Brown et al., 2005; Brown et al., 2009). Specifically, persons with 
low DT exhibit limited ability to endure and persist through negative affective states (Brown et 
al., 2005), and thus are theoretically more likely to lapse and subsequently relapse when 
experiencing nicotine withdrawal. Indeed, studies have shown that low DT is associated with 
number of past failed quit attempts, early treatment dropout, higher withdrawal symptom 
severity and greater withdrawal-related negative affect, and immediacy to smoking lapse (Brown 
et al., 2005; Brown et al., 2009; Brown et al., 2008; Abrantes et al., 2008). Further, results of a 
cognitive-behavioral smoking cessation intervention trial revealed that 45% of quit-day lapsers 
exhibited low DT (Abrantes et al., 2008). Also, as predicted, low DT smokers in this sample 
reported significantly more negative affect on quit day relative to high DT smokers, accounting 
for their higher lapse rates. Together, these findings support the development and evaluation of 
strategies for reducing nicotine withdrawal specialized for smokers low in DT. 
Experimental research indicates that changes in glucocorticoid activity may be involved 
in withdrawal-related relapse, suggesting the hypothalamic-pituitary-adrenocortical (HPA) axis 
may be a crucial intervention target in low DT smokers. Consistent with empirically documented 
dysregulatory effects of stimulant use on glucocorticoid production, habitual smokers exhibit 
elevated levels of basal cortisol as well as amplified cortisol-awakening responses compared to 
non-smokers (Friedman et al., 1987; Steptoe & Ussher, 2006). Within the first day following 
tobacco deprivation (4-24 hours), there is a sharp decline in cortisol concentrations theorized as 
representing a rebound effect caused by the absence of nicotine and other tobacco chemicals 
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from the system (Cohen, al ‘Abasi, & Collins, 2004; Pomerleau, Garcia, Pomerleau, & Cameron, 
1992; Ussher et al., 2006). Though the initial plummet in cortisol begins to increase steadily after 
24-hours, a significant decrease in cortisol concentration has been shown to persist through 6 
weeks after quit (al’Absi et al., 2004; Steptoe & Ussher, 2006). Importantly, more pronounced 
cortisol declines following a quit attempt have been associated with greater experiential distress, 
withdrawal symptom intensity, and rates of early lapse (Cohen, al ‘Abasi, & Collins, 2004; 
Frederick et al., 1998; Ussher et al., 2006).  
This association between post-quit cortisol declines and withdrawal symptom intensity 
has been replicated (Cohen, al ‘Abasi, & Collins, 2004; Frederick et al., 1998; Ussher et al., 
2006), though the nature of the relation has been debated (Steptoe & Ussher, 2006; Ussher et al., 
2006). There have been discrepancies in the research as to whether altered-cortisol secretion 
during a quit attempt is considered an effect of nicotine withdrawal, a putative mechanism 
underlying it, or neither. A few studies find that withdrawal symptoms and detectable cortisol 
declines persist in the event of nicotine replacement therapy (NRT), suggesting nicotine 
deprivation is not sufficient to explain withdrawal-related phenomenon (Steptoe & Ussher, 2006; 
Teneggi et al., 2002). 
Still, there is relatively strong evidence from basic research in animal and human models 
to support the possibility that withdrawal symptoms as the result of nicotine deprivation may be 
mediated, at least in part, by cortisol. As summarized in Frederick et al. (1998), habitual smoking 
disrupts feedback loops involved in HPA-axis regulation. More specifically, nicotine reduces 
glucocorticoid receptor sensitivity by way of repeatedly stimulating cortisol and adrenaline 
release (this finding may explain tobacco drug tolerance). As such, the HPA-axis activity 
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patterns that are observed during nicotine deprivation contrasts that which are seen during 
regular smoking. Removal of nicotine (and therefore, its HPA-stimulatory effects), in turn, 
results in lower cortisol levels, and rebound receptor sensitivity heightening adrenergic activity, 
which may underlie withdrawal-related distress (Frederick et al., 1998; Ussher et al., 2006). This 
work suggests it is worthwhile to investigate whether targeting cortisol through intervention 
strategies would be beneficial. It is possible that interventions that can effectively prevent 
cortisol drops prior to the quit attempt may help protect withdrawal-symptom-vulnerable 
smokers from the detrimental cortisol declines that possibly contribute to relapse.  
 Yoga emerges as a promising candidate to aid smoking cessation in low DT smokers for 
several reasons. First, the application of yoga is supported by its conceptual rationale. Defined as 
a mindfulness-based form of physical exercise, yoga inherently combines two empirically 
supported strategies (i.e., acceptance/mindfulness and physical exercise) for increasing DT and 
for smoking cessation (Bock et al., 1999; Brewer et al., 2011; Brown et al., 2008; Marlatt & 
Chawla, 2007; Smits et al., 2012; Ussher, Nunziata, Cropley, & West, 2001; Ussher, Taylor, & 
Faulkner, 2008). Specifically, yoga encourages individuals to focus on the present moment and 
to use breath (pranayama) as a means toward acceptance and non-reaction through a series of 
potentially uncomfortable and challenging physical postures (asanas; Hewitt, 1977). Consistent 
with this model, initial data from a pilot study from our group shows that an 8-week hatha yoga 
protocol indeed yields significant increases in DT (Medina at al., 2015). Second, initial findings 
indicate that acute and regular yoga practice can reduce nicotine withdrawal and craving 
(Elibero, Van Rensburg, & Drobes, 2011). In one study, this effect was associated with greater 
short-term cessation success (Bock et al., 2010). Third, yoga interventions have shown to 
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effectively reduce perceived stress and regulate cortisol secretion patterns in several disorders 
associated with HPA dysregulation, such as fibromyalgia, cancer, and depression (Arora & 
Bhattacharjee, 2008; Curtis, Osadchuk, & Katz, 2011; Raghavendra et al., 2009; Sternlieb & 
Zeltzer, 2004; Woolery, Myers, Michalsen et al., 2005). Important for those with heightened 
propensity for relapse in response to withdrawal-induced distress, these changes in cortisol have 
been correlated with enhanced positive affect (West et al., 2004). Research suggests that a yoga 
practice may have to be in the vigorous-intensity range (i.e., hot Bikram yoga) to engender the 
effects on cortisol required to reduce withdrawal. Specifically, Scerbo and colleagues reported 
that an acute bout of vigorous aerobic exercise can effectively attenuate cortisol declines and 
reduce associated craving in abstaining smokers (Scerbo, Faulkner, Taylor, & Thomas, 2009). 
Finally, yoga is the fastest growing sport in the US, showing an increase in practitioners from 4.3 
million in 2001 to 10.1 million in 2007, supporting acceptability of the use of yoga for smoking 
cessation.  
Together, these findings promote the hypothesis that yoga is a feasible and effective 
specialized intervention to aid smoking cessation in individuals low in DT. Moreover, research 
suggests programmed yoga may be able to do so by way of targeting an important biobehavioral 
mechanism related to tobacco withdrawal, namely cortisol in the HPA-axis. At this time, it is 
unclear whether regular yoga practice can alter cortisol levels in smokers (ad-libitum) as a means 
to attenuating during-withdrawal subjective distress and cortisol declines during the initial stage 
of a self-guided quit attempt.  
 62 
 
FIGURE 3.1. PROPOSED MODEL OF CAPACITY FOR YOGA TO ENHANCE SMOKING 
CESSATION BY CO-TARGETING LOW DT AND WITHDRAWAL. 
Specific Aims and Hypotheses 
To fill the noted gaps in the literature, the proposed study represents an RCT testing the 
efficacy of a yoga intervention for achieving targeting cortisol, subjective withdrawal, and 
smoking cessation success. We assigned women low in DT (i.e., illustrating elevated AS) to 
randomly receive either an 8-week Vinyasa-style yoga intervention consisting of two weekly 
sessions lasting 60 minutes each [YOGA] or waitlist [WL] prior to a self-guided quit attempt. 
Assessments were completed at baseline, during the intervention, on Quit Day and at 1-week 
following the quit attempt. The primary outcome measures were diurnal salivary cortisol 
concentrations, self-reported withdrawal severity, and self-reported abstinence status (verified by 
biological CO breath exhalation).  
In examining the effect of yoga on ad-libitum cortisol levels in female daily smokers, we 
hypothesized that women assigned to YOGA would exhibit greater reductions in salivary cortisol 
between Baseline and post-intervention (week 9) than those assigned to a waitlist (WL) control 
group. The second part of this aim was to test capacity for YOGA to attenuate drops in cortisol 
during nicotine deprivation. We hypothesized that YOGA would achieve slighter declines in 
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salivary cortisol than WL during the initial 12 hours of a post-intervention quit attempt (slighter 
cortisol reduction between pre-quit Day 1 and Quit Day 2). In addition, we expect that the 
YOGA group would report lower withdrawal symptom severity than WL the evening of Quit 
Day (i.e., 12-hrs post-quit). Our final aim was to evaluate the clinical utility of yoga for smoking 
cessation. Accordingly, we obtained initial effect sizes of the advantage of YOGA over WL for 
achieving abstinence. We hypothesized that YOGA would evidence lengthier abstinence 
duration post-quit than WL. 
Method 
Participants 
Participants included 50 adult female cigarette smokers (M Age = 29.40; SD = 8.30) from 
the Austin, Texas community, randomly assigned to receive either an 8-week yoga intervention 
(n = 33) or waitlist placement (n = 17) prior to initiating a self-guided smoking quit attempt. 
Participants between the ages of 18 and 65 were considered eligible if they reported consuming ≥ 
8 cigarettes per day for the past year; elevated anxiety sensitivity (i.e., scored ≥20 on the Anxiety 
Sensitivity Index (ASI; Reiss, 1991)); at least a 5 out of 10 possible motivation to quit smoking; 
and interest in making a serious quit attempt within the next 2 months (Zvolensky et al., 2008). 
We chose the measure of ASI as our DT index because it best identifies distress-related concerns 
as they pertain to smokers at-risk for relapse (i.e., classified by high fear of interoceptive states, 
such as withdrawal symptoms; Brown et al., 2001; Hughes et al., 1990; Zvolensky et al., 2001). 
Moreover, factor analysis among distress intolerance self-report measures including ASI 
suggests separate measures may likely be tapping a latent general DT factor (McHugh & Otto, 
2012).  
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Exclusion criteria included having practiced yoga or engaged in other mind-body 
practices (e.g., tai chi, meditation) regularly (i.e., once a week or more) within the last year; use 
of other tobacco products besides cigarettes; current severe depression, pregnancy, or any 
medical conditions that could potentially be aggravated by yoga; body mass index ≥ 40 
(classified as obese); possessing cognitive dysfunctions or organic brain syndrome that could 
interfere with their capacity to perform study protocol; receiving concurrent psychotherapy of 
any kind or concomitant medications known to alter HPA-axis functioning; and history of a 
serious mental illness (e.g., psychotic disorder). 
Procedures 
 Overview. See visual depiction of study procedures in Figure 3.2. 
Recruitment. Participants were recruited through variety of sources including, but not 
limited to, advertisements in local newspapers and flyers in the Austin community.  
Initial Eligibility Screening. Individuals who found out about the study via these 
recruitment methods indicated their interest in participating by completing an online prescreen 
survey, which assessed basic eligibility criteria (e.g., distress tolerance, daily smoking, 
motivation to quit). Those who met any of our exclusion criteria were sent an ineligibility email; 
those who reported severe, untreated psychopathology were offered the additional option of a 
psychotherapy referral list. Those who appeared potentially eligible from the prescreen phase 
were phoned by research personnel and asked whether they were willing/able to commit to the 
frequency of clinic visits were asked to come to the university research laboratory for a 2-hr, in-
person Diagnostic Screen Visit. 
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The Diagnostic Screen Visit consisted of informed consent procedures, followed by 
administration of the Mini International Neuropsychiatric Interview for DSM-IV (MINI; 
Sheehan et al., 1999) and self-report questionnaires. In addition to evaluating psychiatric 
inclusion and exclusion criteria, these interviews will allow for assessment of primary and 
secondary diagnoses if applicable. Participants then completed the timeline follow back calendar 
(TLFB; past-week) and carbon monoxide (CO) analysis of breath sample (≥8ppm cutoff; Jarvis 
et al., 1987), evidencing daily smoking status. Those who met criteria and verbally agreed to 
comply with the protocol transitioned to the Baseline portion of the visit, where they were 
randomized and provided additional information regarding their study condition. To account for 
potential confounds to cortisol measurement due sex hormones, the study design also required 
scheduling the combined Screen/BL visit during the luteal phase (~17 days following start-date 
of most-recent period) of participants’ menstrual cycle (Kudielka et al., 2012). 
Randomization. Participants were randomized using a random number generator 
program; we employed block-randomized based on hormonal contraceptive use. 
Baseline (BL). Baseline consisted of randomization, a program orientation, and 
additional lab assessments. BL assessments included of a self-report survey (administered 
through Qualtrics secured software) and hormone (cortisol biomarker) sample collection through 
participant saliva. Since adequate assessment of resting salivary cortisol required a 12-hr ad 
libitum (i.e., still smoking) monitoring period, participant completed saliva samples at home the 
day following their BL visit. Thus, at the close of the BL visit, participants were provided with 
saliva collection materials (2 Salivettes, plastic vials with cotton dental rolls inside; Sarstedt, 
Rommelsdorf, Germany) and were instructed by the experimenter on how to complete (1 after 
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waking, 1 at bedtime) and store them at home over the next 12 hours (al’ Absi et al., 2004). At 
the close of this visit participants also scheduled their smoking Quit Day, which was 9 weeks 
following the BL visit. The evening of BL, the study experimenter called each participant to 
confirm these procedures and address any general program questions/concerns. Upon their 
completion of all baseline procedures (including the return of salivary cortisol samples to the 
lab), participants were compensated $25 for their time and allowed to enter the intervention 
phase of the study.  
Yoga Intervention. The 8-week hatha yoga intervention prescription consisted of twice-
weekly, 60-minute yoga sessions (i.e., 16 classes total) practiced at a local yoga studio in Austin, 
Texas (located ~2 miles from the study site). This studio features a spacious practice space, 
lobby, and storage cubbies; is kept clean and well maintained; offers single-occupant restrooms; 
and provides complimentary filtered water. The studio offered an array of hatha classes 
(primarily of the vinyasa style) throughout the week, taught by Yoga Alliance-certified 
instructors. To meet their prescribed weekly “dose”, participants were allowed to attend any two 
“Vinyasa” or “Align” classes featured on studio’s the schedule each week. Vinyasa is a dynamic 
class involving “flow” sequences (i.e., holding and transitioning through postures synced with 
breath); Align involves similar components, but with a greater focus on holding postures with 
proper alignment. Both Vinyasa and Align are considered all-levels-appropriate classes that 
allowed participants to achieve a moderate-to-vigorous intensity workout. Participants were 
encouraged both by the PI and yoga instructors to complete the entire 60 minutes of each yoga 
session, but urged to do only what is comfortable and not push themselves beyond their physical 
limits. To assess for adverse events and maintain clinical rapport/accountability with 
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participants, our study team conducted a weekly 10-minute phone check-in with each participant 
enrolled in the YOGA condition to discuss progress and address potential barriers to yoga 
practice.  
Waitlist (WL). Participants randomized to the WL control condition at baseline 
completed the same weekly assessment/check-in, Quit Day, and follow-up procedures as YOGA. 
They were compensated for each laboratory visit the same amount as YOGA. At the 1-week 
brief follow-up visit, WL participants were given a voucher to attend 8-weeks of yoga classes at 
the partnering yoga studio. 
Weekly Check-In. At the end of each week of the intervention, all participants (i.e., 
whether enrolled in YOGA or WL) received a weekly call from the study team to gather 
Timeline Followback (TLFB) information (daily cigarette intake) and to assess for any adverse 
events. 
Post-Intervention (Week 9). The week following the end of the intervention (week 9) 
coincided with the week of the smoking quit attempt. During this week, participants performed 
two 12-hr salivary cortisol-monitoring periods—one pre-quit and one on Quit Day (see Figure 
3.2).  
Day 1 (pre-quit). The day prior to Quit Day, participants collected 2 salivary cortisol 
samples (a.m., p.m.), replicating the baseline-monitoring period at home. This was necessary to 
determine the effects of the yoga intervention on average daily salivary cortisol concentrations.  
Day 2 (Quit Day). This included a 12-hr salivary cortisol-monitoring period that 
replicated Day 1 and BL procedures; however, Day 2 (Quit Day) collection was unique in that it 
assessed cortisol changes that occurred during acute nicotine withdrawal the first day of a self-
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guided quit attempt. On this day, participants were asked to initiate their smoking quit attempt 
upon waking (and complete first Salivette). That evening, participants physically reported to the 
lab to (1) return saliva samples from Day 1 and Day 2 a.m.; (2) complete their final p.m. 
Salivette; (3) complete self-report questionnaires assessing withdrawal, subjective distress and 
affective state; (4) provide another hair sample; and (5) provide CO (ppm) readings & self-
reported smoking prevalence for abstinence status. Participants were compensated following this 
Quit Day appointment. 
Self-Aided Quit Attempt. This was a voluntary, unaided nicotine quit attempt 
(Zvolensky et al., 2008), where enrolled participants (i.e., smokers who indicated motivation ≥ 5 
out of 10 to quit smoking) made their best efforts at cessation upon waking on scheduled Quit 
Day (week 9). 
Follow-up Assessment Period. Participants were assessed for 1 week following quit to 
assess smoking abstinence, monitor safety, and document any adverse events. Participants 
reported to the lab 7 days after their quit day (week 10) to provide self-reported (point-
prevalence) and biological indices of smoking abstinence (TLFB & CO readings). At the close of 
this visit WL participants were provided information about the yoga studio, a voucher for two 
months of free, twice-weekly yoga, and a new yoga mat. 
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FIGURE 3.2. PROCEDURES. 
Measures 
Mental Health Screen. The Mini International Neuropsychiatric Interview (MINI); 
Sheehan et al., 1998) assessed diagnostic status at Diagnostic Screen Visit. It is a structured 
interview and can be safely and swiftly conducted on the phone to enable accurate diagnosis of a 
broad variety of mental illnesses, for screening of exclusionary/inclusionary criteria.  
Urine Pregnancy Test. This was conducted for each participant at the screening visit.  
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Anxiety Sensitivity. The 16-item Anxiety Sensitivity Index (ASI; Reiss et al., 1986) 
measures sensitivity to physical (autonomic arousal) sensations. ASI was used to determine 
elevated AS as a screening criterion (eligible participants scored ≥ 20 on the ASI). ASI was re-
assessed at Baseline to ensure that participants maintained their eligibility by the time of 
enrollment. The ASI has good internal consistency and excellent convergent validity with other 
established measures. Chronbach alpha for Baseline ASI in the present sample was 0.864. 
Daily Cigarette Consumption and Continuous Abstinence. The Timeline Followback 
(TLFB) calendar assessed participants’ daily cigarette count at baseline and across the 10-week 
study period. TLFB has demonstrated good reliability and validity in substance use disorders, 
and researchers have recently validated the TLFB for the assessment of adult cigarette use and to 
measure smoking among high AS persons over time (McLeish, Zvolensky, & Bucossi, 2007). 
TLFB was also employed as a measure of self-reported daily smoking abstinence on quit-day 
and during 1-week follow-up. To index initial efficacy of yoga for smoking cessation, we 
compared groups based on the number of days self-reported abstinence was sustained (0–7) in 
the first week following Quit Day. Perkins (2014) argued that this outcome of early quit success 
is ideal for determining pilot efficacy in the context of smoking cessation trials that may be 
underpowered to detect group differences on a binary measure of smoking abstinence. 
Biochemical Verification. The Vitalograph Breathco Carbon Monoxide (CO) monitor 
(Jarvis et al., 1987) was used to assess expired CO. Detected values ≥8 ppm are considered 
indicative of tobacco smoking within the past 24 hrs. Participants were tested during ad libitum 
(screen) and deprivation stages (Quit Day, 1-week follow-up) to verify smoking status.  
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Salivary Cortisol Concentrations. A total of 6 salivary cortisol samples were collected 
from participants over 3 separate 12-hr collection periods, during which morning and evening 
(i.e., diurnal) cortisol was assessed. Saliva samples were collected with Salivettes (Sarstedt, 
Rommelsdorf, Germany), plastic vials with cotton dental rolls inside. Once the samples were 
collected and returned to the lab, they were stored at – 80 degrees Celsius for future processing. 
They were sent to Salimetrics laboratory for extraction, processing, and analysis. To extract 
saliva the samples were centrifuged at 4 degrees Celsius for 5 minutes at 2000xg; samples were 
assayed with an enzyme immunoassay, using an ELISA commercial kit (Diagnostic Products 
Corporation, Los Angeles, CA).  
Salivary cortisol was chosen given its specific temporal utility of assessing cortisol in 
intervention research (McCarthy, 2012) and its ability to capture daily patterns in HPA-axis 
responsivity (McCarthy, 2012). Salivary cortisol samples are scheduled at times anticipating for 
variations in the diurnal pattern (Bailey & Heitkemper, 1991; Kudielka et al., 2012; Weitzman et 
al., 1971). We chose to measure morning cortisol 30-minutes after waking and evening cortisol 
12-hrs following this assessment to reflect the highest and lowest expected cortisol levels for 
each person. 
Minnesota Nicotine Withdrawal Scale-Revised (MNWS-R 79). The MNWS-R 
(Hughes & Hatsukami, 1986) is a validated self-report measure of withdrawal severity rated on a 
5-point Likert scale (0 “none” to 4 “severe”). MNWS-R assesses DSM-IV symptoms of nicotine 
withdrawal. The initial 9 items of the MNWS-R cover primary DSM symptoms of tobacco 
withdrawal—anger, irritability, and frustration; anxiety and nervousness; depressed mood and 
dysphoria; craving to smoke; concentration difficulty; increased appetite, hunger, and weight 
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gain; insomnia and sleep disturbance; and restlessness/impatience (Hughes, 2007). The final 6 
experimental items assess somatic symptoms related to tobacco deprivation, such as 
constipation, dizziness, coughing, dreams or nightmares, nausea, and sore throat (Hughes, 2007). 
The most recent version is the 15-item MNWS, and empirical evidence supports its validity and 
internal consistency (Etter & Hughes, 2006; Hughes, 2007; Weinberger et al., 2007). We 
compared the 15-item total scores between experimental groups to examine differences in 
withdrawal severity on Quit Day. Chronbach alpha for MNWS-R in the present sample was 
0.875. 
 
Measure Screen BL Yoga Intervention Post Follow-up 
* = on Quit Day Wk   -1 0 1 2 3 4 5 6 7 8 9 10 
Consent X            
Adverse Events/ 
Check-in 
  X X X X X X X X X  
Pregnancy Test X            
BMI X            
ASI X X X X X X X X X X X  
Suicide Scrn. X            
Demographic X            
TLFB  X X X X X X X X X X X 
CO (ppm)  X         X X 
12-hr Salivary 
Cortisol 
 X         X     X*  
FTND  X   X   X   X  
MNWS-R           X*  
Debrief/Exit 
interview 
           X 
 
TABLE 3.1. ASSESSMENT SCHEDULE. 
Data Analytic Strategy 
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Effect of Yoga on Cortisol. In order to analyze changes in 12-hr cortisol as the result of 
yoga from pre-to-post intervention and from post-intervention to Quit Day (i.e., during 
withdrawal), we used mixed effects multilevel modeling (MLM) in SPSS® Version 24. There 
are several advantages of this approach over other strategies for evaluating longitudinal data, 
including the capacity to include subjects regardless of missing data. The natural log 
transformation was applied to our cortisol outcome variable to reduce skewness. We employed 
the Diagonal error covariance matrix based on goodness of fit determined by information 
criterion, AIC/BIC. 
We used a single, 2-level MLM to test our hypotheses. Our MLM included assessment-
day (see next paragraph) and time of day [TIME_OF_DAY] as level 1 predictors of outcome, 
and study condition [COND, coded “0 = Yoga”, “1 = WL”] as a level 2 predictor (moderator) of 
our outcome. Given that withdrawal-related cortisol declines should theoretically be contingent 
on nicotine deprivation, we also factored participants’ success at achieving a 12-hr abstinence on 
Quit Day into our analysis. Accordingly, our final model also included the additional level 2 
grouping variable for quit-attempt status [QUIT_ATTEMPT, coded dichotomously as “attempter 
= 0”, “lapser = 1”]. Age, BMI, and baseline FTND and ASI were included as covariates in our 
MLM, but were dropped from the final model, as they were not significant.  
Since assessment day was a categorical variable (not a continuous variable) and was 
comprised of 3 levels (BL, POST, and QUIT day), the effect of day was examined using 2 
dummy variables. In dummy variable coding of a categorical variable, one category (in this case, 
POST) is designated as the “reference” category. Then dummy variables are created for the other 
2 categories (DBL and DQuit). When following this coding strategy, the effects of each dummy 
 74 
variable represents the difference between the category that the dummy variable represents 
(either BL or QUIT day) and the reference category (POST). Accordingly, we included two 
Level 2 dummy variables [DBL and DQuit] in our model to test the difference in cortisol 
concentration between post-treatment Day 1 and each of the other two days. TIME_OF_DAY 
was centered at the midpoint of morning and evening (coded as “a.m. = -0.5” and “p.m. = 0.5”) 
in order to interpret the main effect for each dummy (Dquit, DBL) as the difference in diurnal 
cortisol average between that day and the reference day. The interaction between 
TIME_OF_DAY and each dummy reflected the change in diurnal slope between Dquit or DBL and 
the reference day. 
Our final MLM composite model for predicting salivary cortisol concentrations included 
the main effect of each Level 1 and 2 predictor (Dquit, DBL, TIME_OF_DAY, QUIT_ATTEMPT, 
COND), in addition to the various combinations for modeling two-, three-, and four-way 
interactions between each dummy-coded day (Dquit, DBL) and each other predictor (with the 
exception that QUIT_ATTEMPT did not interact with DBL or its interactions). Significance of 
the coefficient for the two-way DBL x COND interaction reflected group differences in average 
diurnal cortisol between BL and post-intervention. Significance of the coefficients for either the 
three-way (DQUIT x COND x QUIT_ATTEMPT) interaction (modeling condition differences in 
the change diurnal cortisol levels between post-intervention and Quit Day) or four-way (DQUIT x 
COND x QUIT_ATTEMPT x TIME_OF_DAY) interaction (modeling condition differences in 
the change in diurnal cortisol slope between post-intervention and Quit Day based on quit status) 
were used to test effects of yoga during withdrawal.  
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Effect of Yoga on Subjective Withdrawal. We employed ANCOVA to test the quit-
status-moderated effect of study condition (i.e., COND x QUIT_ATTEMPT interaction) on 
subjective withdrawal symptom severity (MNWS-R-15) on Quit Day. Baseline FTND and ASI 
were entered in the model as covariates. 
Initial Efficacy of Yoga for Smoking Cessation. A Poisson regression with a log link 
function, controlling for baseline FTND and ASI, was run to predict the effect of COND on the 
count distribution for the number of days (0-7) until relapse following a quit-attempt. Days 
abstinent was determined based on values reported on the TLFB for the 7 days between Quit Day 
and 1-week Follow-Up (0 days of abstinence were counted Quit Day lapsers). We examined this 
relation both among the entire sample (i.e., intent-to-treat (ITT)) and second, among study 
completers only (i.e., excluding dropouts). For study dropouts using ITT, lapse was assumed 
(i.e., 0 days of abstinence were counted).  
 
Results 
Participant Characteristics 
Our final sample consisted of 50 female smokers, ranging in age from 19 to 53 (M = 
29.40, SD = 8.30), randomized to either YOGA (n = 33) or WL (n = 17). Randomized 
participants reported smoking on average 11.25 cigarettes per day (SD = 11.26) at baseline; 
scored a mean of 3.56 (SD = 2.43) on the FTND (indicative of low to moderate nicotine 
dependence; Pomerleau, Majchrezak, & Pomerleau, 1989); and reported an average motivation 
to quit of 6 out of 10. ASI at baseline (M = 24.16, SD = 10.10) for the total sample approached 
clinical norm for individuals diagnosed with anxiety disorders (Peterson & Reiss, 1992). Body 
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mass index (BMI) for the total sample was in the normal range (M = 23.15, SD = 4.95) (see 
Table 3.2 for descriptive statistics divided by group).  
      Yoga     (N = 33) 
Waitlist 
(N = 17) 
Total 
(N = 50) 
Variable    M         SD             M        SD M        SD 
Age 
BMI 
30.58       7.88 
23.81       5.74 
           27.12      8.85 
           21.99      3.06 
          29.40      8.30 
          23.15      4.95 
ASI 23.42       9.27            25.59     11.73           24.16      10.10 
FTND 3.64         2.43             3.41       2.48            3.56         2.43 
CO (ppm) 16.06       13.17                          12.06      11.11           14.70      12.54 
Avg. Cigs/Day 11.55       4.65            10.74       5.34           11.25       4.86 
 
TABLE 3.2. BASELINE SMOKING AND CLINICAL CHARACTERISTICS. 
The sample consisted primarily of young, urban, non-Hispanic White (80%, n = 40) 
female adults. Of the 5 (10%) participants who identified ethnically as Hispanic/Latina, 4 
identified racially as White, and 1 identified as Native American. Among non-Hispanic 
participants, 45 (90%) identified their race as White, 2 identified as Asian/Asian American (4%), 
2 identified as Native American, and 1 identified as Black/African American (2%). Majority 
(94%; n = 47) of our total sample was unmarried (i.e., either single (66%), living with a partner 
(20%), divorced (6%), or widowed (2%)). Regarding education, all but one participant gained at 
least a high school degree, and 48% were college graduates or higher (12% reported attaining a 
graduate degree). Regarding SES, 44% reported earning an annual household income of below 
$25,000. See Table 3.3, for additional participant demographic statistics. 
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Total Sample   
N = 50 n %  
 
Race 
   
     White 46 92  
     Black/African American 1 2  
     Asian  2 4  
     Native American 3 6  
Ethnicity 
     Hispanic/Latino  
 
5 
 
10 
 
 
Household Income    
     <$25,000 22 44  
     $25,000-$49,000 
     $50,000-$74,000 
     >$75,000 
     Missing/not reported 
 
Occupational Status 
    Employed Full Time 
    Employed (Part-Time) 
    Dependent - spouse/student 
    Dependent - public/private aid 
    N/A or not reported 
17 
5 
1 
5 
 
 
28 
14 
1 
1 
6 
34 
10 
2 
10 
 
 
56 
28 
2 
2 
12 
 
    
 
TABLE 3.3. PARTICIPANT DEMOGRAPHICS. 
Randomization and Group Baseline Equivalence 
Our attempt at randomization yielded unequal group sizes (33 = YOGA, 17 = WL). 
MANOVA was used to examine condition differences at Baseline in demographic and clinical 
characteristics. Results showed that WL and YOGA did not differ in baseline characteristics of 
BMI, age, nicotine dependence (FTND), reported average daily cigarette count, or ASI (p’s > 
0.17). Refer to Table 3.2 for baseline descriptive statistics on AS and smoking-related variables. 
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In addition, the model revealed no differences between study conditions in baseline salivary 
cortisol parameters (p’s > 0.22). Out of 50 enrolled participants, 49 provided a.m./p.m. Salivette 
pairs at Baseline (i.e., 98 samples collected in total). Two of the 98 samples collected were below 
the detectable range for salivary cortisol analysis. Outliers were removed if they were ≥ 3 SDs 
above the mean for their respective data points, resulting in two outliers being removed (final 
salivary cortisol n = 46). (see Table 3.4).  
 
 
Cortisol 
(µg/dL) 
                  Yoga     Waitlist      Total 
Baseline       
Morning  
M 0.429 0.437 0.432 
 
 SD 0.255 0.228 0.244  
 n 31 16 47  
Evening  
M 0.236 0.142 0.203 
 
 SD 0.485 0.2 0.409  
 n 30 16 46  
Post (Pre-Quit)       
Morning  
M 0.41 0.399 0.406 
 
 SD 0.215 0.203 0.207  
 n 18 12 30  
Evening  
M 0.095 0.099 0.097 
 
 SD 0.0726 0.104 0.085  
 n 18 12 30  
Quit Day      
Morning  
M 0.38 0.274 0.336 
 
 SD 0.187 0.153 0.179  
 n 17 12 29  
Evening  
M 0.088 0.115 0.098 
 
 SD 0.059 0.053 0.057  
 n 19 12 31  
 TABLE 3.4. SALIVARY CORTISOL CONCENTRATIONS (µg/dL) SEPARATED BY DAY, 
TIME OF DAY, AND STUDY CONDITION. 
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Retention and Dropout 
Participant flow and dropout are depicted in the CONSORT diagram below (Figure 3.3). 
The 31 participants (YOGA = 19, WL = 12) who attended the Quit Day visit and completed 
post-intervention survey were considered “completers” and those who did not were considered 
study “dropouts.” Accordingly, total attrition was 19 (38%). MANOVA revealed that there was 
not a significant difference between the 31 completers and 19 dropouts at baseline in age, BMI, 
clinical characteristics (FTND, ASI, daily cigarette count), or cortisol levels (p’s > 0.25). 
Fourteen participants (42%) dropped out from the YOGA condition, and 5 (29%) from WL. Chi-
square analyses revealed that study attrition did not differ significantly between conditions (c2 = 
1.20, p = .27). 
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FIGURE 3.3. CONSORT DIAGRAM 
Self-Guided Quit-Attempt 
Verified by biological CO levels (ppm ≥ 8), 17 of 31 (55%) study completers who 
attended the Quit Day visit successfully attempted to quit smoking on Quit Day. In YOGA, 10 
 
 
Yoga Intervention (n = 33) 
 
 
Waitlist Control (n = 17) 
Post-intervention 
Attended Quit Day visit + completed 
4 cortisol samples & survey 
assessment (n = 19) 
 
• Total attrition (n = 14) 
 Pre-intervention drop (n = 6) 
 Lost to follow up (n = 8) 
- Logistical issues (4) 
- Injury (1) 
- unknown (9) 
 
 
 
Assessed for eligibility  
(n = 560) 
 
Excluded in prescreen phase (n = 503) 
Not meeting inclusion criteria (n = 438) 
Declined to participate (n = 65) 
 
Excluded in screen visit (n = 7) 
Not meeting inclusion criteria (n = 2) 
Declined to participate (n = 5) 
 
 
Randomized 
(n = 50) 
Analyzed  
• ITT analysis (n = 33) 
• Cortisol MLM analysis (n = 30) 
- 1 outlier excluded  
- 2 Salivettes not analyzed due to 
poor sample quality 
 
(MLM analyses include all subjects, 
regardless of missing data and do not require 
imputation of missing data. MLM included all 
participants who provided analyzable baseline 
cortisol sample pairs (n = 46)) 
  
Analyzed  
• ITT analysis (n = 17) 
• Cortisol MLM analysis (n = 16) 
- 1 outlier excluded   
 
 
Post-intervention  
Attended Quit Day visit + completed 4 
cortisol samples & survey assessment 
(n = 12) 
 
• Total attrition (n = 5) 
Pre-intervention drop (n = 4) 
Lost to follow up (n = 1) 
- unknown (9) 
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out of 19 (52.63%) participants achieved 12-hr abstinence; in WL, 7 out of 12 (58.33%) 
participants achieved 12-hr abstinence (c2 = 0.10, p = .76). 
Intervention Adherence 
Twenty percent of the sample (see CONSORT diagram, Figure 3.3) dropped out during 
the first week (before yoga sessions began). Two participants dropped out (both in YOGA) 
during the early intervention phase (i.e., prior to completing 1 week or less of yoga), and the 7 
remaining (1 in WL, 7 in YOGA) occurred between weeks 3-9. Among the 19 study completers 
assigned to YOGA, yoga class compliance was generally poor; on average, participants attended 
just over half of the assigned, 16-class yoga dose over 8 weeks (M = 8.44 classes; SD = 4.20). 
Hypothesis Testing.  
 Effect of Yoga on Cortisol. Contrary to prediction, our 2-level MLM showed that the 
(DBL x COND) effect on salivary cortisol was not significant (b = .021, t(109) = .500, p = 0.618), 
such that there was no significant difference between conditions in the change in average 
salivary cortisol levels between BL and post-treatment. The model also suggested that yoga did 
not influence during-withdrawal cortisol, as neither the 3-way (DQUIT x COND x 
QUIT_ATTEMPT), nor the 4-way (DQUIT x COND x QUIT_ATTEMPT x TIME_OF_DAY), 
interactions were significant. The non-significant (DQUIT x COND x QUIT_ATTEMPT) 
interaction (b = -.092, t(74) = -1.494, p = 0.139) revealed that there was no significant difference 
between conditions in the change in average salivary cortisol levels between post-treatment Day 
1 and Quit Day 2. The non-significant DQUIT x COND x QUIT_ATTEMPT x TIME_OF_DAY 
interaction (b = -.016, t(73) = -.131, p = 0.896) revealed that there was no significant difference 
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between conditions in the change in salivary cortisol slope between post-treatment Day 1 and 
Quit Day 2.  
When we re-ran the model, however, dropping the 4-way interaction term, the (DQUIT x 
COND x QUIT_ATTEMPT) effect on salivary cortisol concentrations became marginally 
significant, b = -.097, t(87) = -1.936, p = 0.056. To further investigate this relationship, we 
interpreted the two-way (Dquit x QUIT_ATTEMPT) interaction effect within each group. 
Examining the relation in WL required first reverse-coding the COND variable (i.e., 0 = WL, 1 = 
YOGA) and then re-running the model. Results showed that the (Dquit x QUIT_ATTEMPT) 
relation was significant for YOGA, b = 0.080, t(97) = 2.218, p = .029, but not for WL, b = -
0.017, t(106) = -0.404, p = .687. This illustrated that the change in average diurnal cortisol from 
pre-quit Day 1 to Quit Day 2 for YOGA depended on abstinence status. Specifically, average 
diurnal cortisol concentrations in YOGA significantly reduced from pre-quit to quit day for 
attempters, while in lapsers, concentrations increased (see Figure 3.4). For WL, quit-status did 
not moderate the difference in cortisol observed from Day 1 to Day 2, as cortisol reduced for 
both attempters and lapsers (though slighter drops were observed in lapsers, as would be 
expected). 
Figure 3.5 and Figure 3.6 display morning and evening cortisol changes, respectively. 
Indicated by a non-significant (COND*Dquit) interaction within quit attempters 
(QUIT_ATTEMPT coded “0” = attempters, “1 = lapsers”), condition did not moderate the 
difference in morning (b = 0.026, t(53) = -.313, p = .755) or evening (b = -0.003, t(63) = -.068, p 
= .946) cortisol concentration differences between pre-quit Day 1 and Quit Day 2. Important to 
note, we observed morning drops in cortisol between pre-quit and quit day (i.e., in the expected 
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direction given nicotine deprivation) for attempters in both conditions (Figure 3.5). However, in 
the evening YOGA attempters demonstrated no change, and WL attempters peculiarly increased 
their cortisol on average (Figure 3.6). 
. 
FIGURE 3.4. CHANGE IN AVERAGE DIURNAL SALIVARY CORTISOL FROM POST-
TREATMENT (PRE-QUIT DAY) TO QUIT DAY AS A FUNCTION OF CONDITION AND 
QUIT STATUS 
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FIGURE 3.5. CHANGE IN MORNING SALIVARY CORTISOL FROM POST TREATMENT 
(PRE-QUIT DAY) TO QUIT DAY AS A FUNCTION OF CONDITION AND QUIT STATUS. 
 
 
 
 
FIGURE 3.6. CHANGE IN EVENING SALIVARY CORTISOL FROM POST-TREATMENT 
(PRE-QUIT DAY) TO QUIT DAY AS A FUNCTION OF CONDITION AND QUIT STATUS. 
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To better understand the role of nicotine deprivation status as a determinant of diurnal 
cortisol alterations, we examined QUIT_ATTEMPT as a moderator of cortisol concentration 
changes across conditions by re-running our model with COND coded YOGA = “-0.5”, WL = 
“0.5.” Consistent with the extant nicotine withdrawal literature, we found that the Dquit x 
TIME_OF_DAY interaction was significant for attempters, b = 0.144, t(75) = 3.146, p = .002), 
but not for lapsers, b = -.039, t(76) = -.787, p = .694. As depicted in Figures 3.7 and Figure 3.8, 
the relation was such that morning cortisol reduced for successful attempters between Day 1 and 
Day 2, yielding a flatter diurnal cortisol slope on Quit Day. 
 
FIGURE 3.7. CHANGE IN DIURNAL SALIVARY CORTISOL FROM POST-TREATMENT 
(PRE-QUIT DAY) TO QUIT DAY FOR SUCCESSFUL ATTEMPTERS. 
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FIGURE 3.8. CHANGE IN DIURNAL SALIVARY CORTISOL BETWEEN POST-
TREATMENT (PRE-QUIT DAY 1) AND QUIT DAY 2 FOR LAPSERS. 
 
Specific Aim 2. Mean MNWS-R (15-item) for the 31 individuals who completed the 
measure the evening of Quit Day was 23.66 (SD = 11.22). Results of ANCOVA showed that the 
COND x QUIT_ATTEMPT interaction effect on MNWS-R was not significant (i.e., F(1,28) = 
0.269, p > .05), revealing no mean difference between YOGA and WL in withdrawal severity 
based on quit-attempt status. Estimated mean for YOGA was 24.90, (SD = 10.18) and for WL 
was 22.66 (SD = 13.30). Contrary to what is shown in the smoking literature (Weinberger et al., 
2007; Toll et al., 2007), neither QUIT_ATTEMPT (main effect) nor the covariates included in 
the model (Baseline FTND, ASI) predicted MNWS-R (p’s > 0.053). However, the non-
significant baseline ASI effect on MNWS-R was large but not significant (F(1,28) = 4.156, p = 
.053, η2 = 0.141). 
 Specific Aim 3. Results of our Poisson regression using an ITT approach (N = 50) 
revealed that neither FTND (b = 0.006, χ2(1) = 0.009, p = .923) nor COND (b = 0.123, χ2(1) = 
0
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0.037, p = .663) were significant predictors of days abstinent, with the model predicting a mean 
of 1.25 days abstinent for YOGA (SE = .198) and 1.11 days abstinent for WL (SE = .260). 
Baseline ASI significantly predicted days abstinent (b = 0.031, χ2(1) = 5.793, p = .016), showing 
that higher pre-treatment ASI was associated with lengthier abstinence duration. The completer 
analysis (n = 31) showed similar results, as there was no effect of COND (b = 0.395, χ2(1) = 
0.632, p = .427) or baseline FTND (b = 0.038, χ2(1) = 0.140, p = 0.708). The model estimated 
mean abstinence duration of 2.237 days for YOGA and 1.506 for WL. In contrast to the ITT 
analysis, however, baseline ASI did not predict days abstinent for completers (b = 0.033, χ2(1) = 
1.889, p = 0.169).  
Exploratory Analysis of the Effect the Yoga Intervention on Smoking Behavior. 
 Tapering. Though participants were not instructed to change their cigarette consumption 
before Quit Day, it is possible that engagement in yoga (i.e., a regular health behavior) 
influenced participants to alter their smoking habits. Since significantly reducing one’s nicotine 
dependence via tapering pre-quit could impact the experience of withdrawal on Quit Day, a 
separate MLM analysis evaluating the longitudinal change in weekly TLFB point-prevalence 
revealed a significant main effect of Time (b = -1.721, t(93) = -6.633, p = 0.000) and a 
significant COND*Time effect (b = 0.917, t(92) = 2.167, p = 0.033), indicating YOGA reduced 
self-reported smoking over time. 
Discussion 
 The present study represents a novel effort to translate basic research findings to an RCT 
designed to target withdrawal-related relapse through yoga. We evaluated the efficacy of an 8-
week hatha yoga intervention to (1) reduce cortisol levels prior to a self-guided tobacco quit 
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attempt; (2) attenuate cortisol drops and subjective nicotine withdrawal symptoms during the 
initial 12-hrs post-quit; and (3) achieve superior smoking cessation outcomes to a waitlist control 
group, evidenced by longer sustained abstinence during 1-week follow-up.  
Results were generally inconsistent with our hypotheses. Specifically, we failed to find 
pre-to-post intervention differences between the yoga condition (YOGA) and waitlist (WL) in 
ad-libitum diurnal salivary cortisol concentrations. Analyses also failed to show that yoga was 
able to target withdrawal parameters during a post-intervention quit-attempt (week 9). 
Specifically, there were no group differences on quit-day in subjective withdrawal symptoms or 
in the change in diurnal cortisol from pre-quit day. Consistent with this pattern, post-quit 
abstinence duration was equivalent between conditions, disproving our hypothesis that YOGA 
would by superior to WL for achieving early smoking cessation. Promising from a harm-
reduction perspective, however, a final exploratory analysis showed the yoga intervention 
influenced participants to taper down their weekly cigarette usage prior to quit.   
Despite null findings across major aims, our trial represents an innovative application of 
yoga. This study is one of the first behavioral intervention attempts to reduce hypercortisolism in 
smokers, positioning it as a stepping point for further investigation of ways to address tobacco 
related HPA-axis dysregulation. One other trial to our knowledge has applied programmed yoga 
for smoking cessation and nicotine withdrawal symptoms (Bock et al., 2012). However, ours is 
the first to our knowledge to explore cortisol as a potential mechanism of yoga’s influence on 
withdrawal and withdrawal-related relapse in distress-vulnerable smokers.   
Our study also adds to the growing number of intervention studies finding capacity to 
detect changes in cortisol secretion patterns across time through repeated saliva sampling. 
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Speaking to the reliability of our methodology, we found that for each day that samples were 
taken (i.e., baseline, post-intervention, quit day), 12-hr patterns observed were in accordance 
with the normal trajectory of decline from morning to evening (Edwards, Clow, Evans, & 
Hucklebridge, 2001). Furthermore, participants who successfully attempted to quit smoking 
illustrated the hypothesized during-withdrawal cortisol drops (Cohen, al’Absi, & Collins, 2004; 
Frederick et al., 1998; Ussher et al., 2006). We were also able to detect changes related to 
nicotine deprivation. Across study conditions, successful quit attempters reduced their diurnal 
average and slope in salivary cortisol between pre-quit day and quit day. Subjective withdrawal 
ratings on quit day were consistent with experience of withdrawal. The sample mean for the 
MNWS-R was 23.66 (SD = 11.22), which is comparable to other studies examining the effects of 
attempted nicotine deprivation (Hughes & Hatsukami; Toll et al., 2007). Together, these results 
encourage future attempts to compare salivary cortisol levels before and after a tobacco quit 
attempt in an intervention context.  
Potential explanations for our lack of significant between-group differences are small 
sample size and intervention non-adherence. First, high attrition lowered our sample size and 
thus statistical power for detecting effects. The study was originally powered for our target N of 
50 participants (assuming approximately group equal sizes) to be able to detect medium to large 
effects. Our randomization procedure yielded unequal groups (YOGA = 33; WL = 17). In 
addition, 38% (n = 19) of our sample dropped out following enrollment reducing our final 
sample size to 31. This is within the typical range of attrition rate among other behavioral 
smoking cessation interventions (Bryant et al., 2011; Stead & Lancaster, 2012; Stead, Carroll, & 
Lancaster, 2000). Nevertheless, it is possible that attrition prevented our ability to detect between 
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group differences on some outcomes, particularly instances when there may have been smaller 
effect sizes. Small group cells can be particularly problematic for detecting statistical differences 
between study conditions in cortisol biomarker due to wide sample heterogeneity (Kirschbaum & 
Hellhammer, 2007). 
The nature of the relation found between covariates and one of our outcomes supports the 
likelihood that power influenced detection of effects. Results of our test of between-group 
differences in subjective nicotine withdrawal symptoms did not support the prediction that 
YOGA would display less severe withdrawal (MNWS-R scores) than WL; this was not 
necessarily surprising given that we were unable to find yoga efficacious for targeting cortisol 
(i.e., the mechanism considered as giving rise to withdrawal distress). Interestingly, however, 
covariates, baseline nicotine dependence (FTND) and AS (ASI), did not predict withdrawal 
either, which is inconsistent with the evidence in the smoking literature supporting the 
convergent validity of the MNWS-R (Weinberger et al., 2007; Toll et al., 2007). The relation 
between ASI and MNWS-R approached marginal significance with a large effect size, 
highlighting the likelihood that attrition may have played a role in reducing statistical power to 
detect effects. 
We employed MLM to examine cortisol aims because it is able to address some of the 
challenges posed by having large amounts of missing data. Though MLM cannot correct for 
biomarker heterogeneity per se, it is a preferred ITT approach for evaluating nested, longitudinal 
data given its advantage of being able to include subjects regardless of missing data and adjust 
model parameters for observation frequency and study duration (i.e., characteristics that optimize 
power in smaller samples; Fritz & MacKinnon, 2007). However, attrition may have significantly 
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impacted MLM findings as well. Because all attrition occurred prior to or during the intervention 
phase, no post-intervention cortisol samples were gathered for dropouts. Accordingly, MLM 
analysis (n = 46) estimated post-intervention levels for dropout participants in the model 
equation based off of baseline levels. It is possible that data projections from baseline introduced 
significant error variance reducing the sensitivity of our test.  
 In addition to high rates of dropout, we observed poor intervention adherence. 
Participants assigned to YOGA attended on average just over half of the assigned, 16-class yoga 
dose over 8 weeks, ultimately preventing our ability to evaluate the yoga prescription we 
suspected would be beneficial for targeting nicotine withdrawal and early relapse. Worth 
nothing, the proportion of total of yoga classes attended in our study was slightly greater than 
that which was observed a recent aerobic exercise intervention trial conducted in high AS 
smokers, which found that participants attended 44% (20 out of 45) of the 30-minute sessions 
assigned (Smits et al., 2016). On the contrary, other yoga intervention trials conducted in female 
smokers (who were not screened for AS; Bock et al., 2013) and in other low DT samples (i.e., 
women with stress-induced eating tendencies; Hopkins et al., 2016) have achieved superior 
adherence to ours. Bock and colleagues (2012) achieved low attrition and 76% yoga class 
adherence in an RCT that evaluated a yoga intervention of comparable style, duration, and dose-
intensity in 55 female smokers. (Bock et al., 2012). Overall, these discrepancies underscore the 
difficulties engaging tobacco users with elevated AS in health behavior change strategies.  
Potentially related to attrition and adherence differences, our	findings related to 
withdrawal and cessation were inconsistent with those by Bock et al. (2012). Results from this 
trial showed that 8-week Vinyasa yoga + standard smoking cessation CBT was superior to CBT 
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+ a wellness contact control for reducing withdrawal symptom severity and achieving short-term 
(12-hr and 7-day) abstinence (Bock et al., 2012). The discrepancy between our findings and 
theirs suggests that providing access to a yoga intervention is insufficient for its effective 
implementation, particularly for populations characterized by behavioral avoidance (i.e., tobacco 
smokers with elevated AS). Findings by Bock and colleagues (2012) also suggest that yoga may 
be most clinical effective for treating smoking when used to augment the effects of other 
behavioral intervention strategies. This may especially be the case for more severe clinical 
groups of smokers, such as those with elevated AS, who may benefit from more intensive 
methods to enhance treatment adherence and boost therapeutic efficacy of standard treatments. 
Our exploratory analysis, showing yoga that, relative to WL, YOGA participants effectively 
reduced their cigarette intake from Baseline to Week 9, promotes programmed yoga as a 
potentially effective preparatory aid for quitting smoking. As such, its effects may also be 
optimized when applied in combination with strategies that can acutely mitigate early-lapse 
processes.  
 Given that we failed to meet aims pertaining to cortisol, answers to questions of whether 
(1) yoga can down-regulate cortisol in smokers prior to a quit attempt, and (2) this effect can 
engender resistance to post-quit cortisol drops during deprivation, remain unknown. We focused 
on cortisol as a putative mechanism of nicotine withdrawal severity and early relapse (Cohen, al 
‘Abasi, & Collins, 2004; Frederick, 1998; Pomerleau, Garcia, Pomerleau, & Cameron, 1992; 
Ussher et al., 2006). Yoga was chosen as our strategy for targeting cortisol in smokers given 
outcomes from previous exercise/yoga intervention trials, finding 6-12 week yoga beneficial for 
altering cortisol within conditions marked by HPA-axis dysregulation (Banasik et al., 2011; 
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Riley & Park, 2015; Ross & Thomas, 2010; Woolery et al., 2004). Though no behavioral 
intervention studies to our knowledge have made attempts at addressing chronic 
hypercortisolism in nicotine users, studies support 8-week moderate-to-vigorous intensity yoga 
as capable for lowering diurnal cortisol in other groups. Banasik and colleagues (2011), for 
example, compared 8-week, twice-weekly Iyengar-style yoga (i.e., comparable yoga “dose” to 
our study) to a waitlist control for lowering salivary diurnal cortisol levels in 18 breast cancer 
survivors, finding reduced a.m. and p.m. concentrations by post-treatment. Though the discussed 
findings by Bock et al. (2012) encourage the possibility that an 8-week dose is sufficient for 
augmenting smoking cessation CBT outcomes, their effects have not been replicated and do not 
speak to whether cortisol was mechanism of outcome. Our findings call for further research 
examining efficacy of yoga for mitigating biological withdrawal processes in smokers. Under 
this aim, studies should investigate dose-response relations by manipulating dose.  
 In addition to attrition and adherence, another potential limitation relates to timing of 
measurement. By assessing cortisol only at baseline and post-yoga, it is possible that we failed to 
capture meaningful during-intervention changes that occurred, particularly during weeks wherein 
greater study participation and yoga class attendance was observed. Furthermore, participants 
collected cortisol samples at home, therefore, we cannot verify that instructions were followed. 
Measurement of peak diurnal cortisol (i.e., 30 minutes after waking) is particularly contingent on 
successful timing of measurement given that levels vary greatly over the CAR trajectory. Even 
slight deviation from the collection protocol could have introduced significant error variance into 
our between-day comparisons.  
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Encouraging of the feasibility/acceptability of yoga as a clinical treatment, we did not 
face difficulties recruiting interest for participation the Austin, Texas community. As a 
qualitative observation, most of our enrolled participants stated eagerness to initiate yoga during 
the program orientation during the baseline visit. Behavioral performance, however, was clearly 
inconsistent with stated interests. As an attempt to bolster engagement and collect smoking data, 
the study PI and laboratory research assistants called each participant weekly to briefly check-in 
regarding their participation. However, this strategy failed to foster adequate motivation and 
accountability to reinforce adherence. Guided by the impressive adherence results from Bock et 
al. (2012), it is advisable that future yoga intervention trials include components to bolster 
clinical and social support, as well as to teach sills for successful behavior change and stress-
coping. Strategies used by Bock and colleagues (2012) included evidence-based counseling and 
a cohort enrollment procedure. The advantages of using of group social support and combining 
behavioral support with other behavioral and pharmacological interventions to optimize exercise 
adherence and effectiveness is also supported by outcomes from standard care smoking cessation 
interventions (Stead & Lancaster, 2012).  
We also considered clinical explanations relevant to AS smokers for non-adherence. A 
secondary analysis from the aforementioned RCT on hot yoga for affective eating by Hopkins 
and colleagues published in 2015 found that BMI and low DT were time-varying predictors of 
weekly adherence rates. This suggests that the very characteristic we aimed to address with yoga 
may have prevented participants from reaping benefit. Though identification of adherence 
barriers is beyond the scope of the present study, follow-up analysis examining adherence 
predictors is warranted. Overall, the summarized information suggests that successful yoga 
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programs in the future will have adequate resources and individually tailored clinical supports in 
place to promote engagement and commitment, while addressing concerns that could negatively 
impact behavior.  
In light of our findings and their limitations, we make several final recommendations for 
further research. To further understand the clinical utility and mechanisms underlying the effects 
of yoga on withdrawal and smoking cessation, additional intervention trials with multiple 
intervention arms will be needed. This will allow for determining the comparative advantage of 
yoga-augmented treatment over stand-alone yoga for smoking and its underlying mediators. In 
order to establish evidence of dose-efficacy and specificity for the potential benefits of yoga in 
tobacco users, these experimental trials should also compare various yoga styles, intensities, and 
intervention durations. We suggest that future efforts to examine cortisol as a driving mediator of 
the effects of hatha Vinyasa effects pay particular attention to the practical and methodological 
limitations noted from the present study. Finally, given that our results only extend to women, 
future studies are warranted to examine yoga’s effect on cortisol and nicotine withdrawal in men, 
especially men with elevated AS. 
The overarching objective of this study was to evaluate biobehavioral effects of a yoga 
intervention designed for targeting nicotine withdrawal and risk-of-relapse in smokers with low 
DT (i.e., elevated AS). Results indicated 8-week hatha Vinyasa yoga was not effective for 
targeting cortisol, ameliorating withdrawal, or achieving abstinence in smokers. Two major 
factors we suspect undermined potential intervention efficacy with yoga were attrition and 
intervention non-adherence. Though our aims were not supported, this study adds to the growing 
body of literature evaluating the mental and physical health effects of yoga. Furthermore, results 
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add to the emerging body of work investigating exercise as a strategy to address the maladaptive 
role of affective vulnerabilities on additive behaviors. In conclusion, this RCT represents a novel 
attempt to translate experimental paradigms to clinical treatment. Limitations and findings hold 
recommendations for future efforts to explore the role of yoga in the withdrawal-relapse relation.  
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General Discussion 
This research was guided by the need for improved treatments for addictive behaviors. A 
common aim of the three RCTs presented in this dissertation was to evaluate the benefits of 
varied exercise modalities in populations with factors that put them at risk for maladaptive 
behavioral coping tendencies (e.g., binge-eating, treatment dropout, smoking). With a particular 
focus on ways to modify DT and its consequences, the specific objective of this line of work is to 
identify potential moderators and explanatory mechanisms of the effects of aerobic exercise and 
yoga in samples with low distress tolerance. Support for the aims across studies was mixed. 
Summary of Findings 
Studies 1 and 2 aimed to target distress intolerance directly. Study 1 represents a 
secondary analysis from a previous trial conducted by our research group, which found efficacy 
of a brief, 2-week vigorous-intensity exercise intervention for reducing AS. Our objective was to 
examine gender as an individual difference predictor of AS response to aerobic exercise. Results 
showed that AS reduced less-readily for women as compared to men in response to brief, two-
week exposure to vigorous aerobic activity. This finding pointed to the possibility that clinical 
responses to exercise vary by gender, perhaps due to differences between sexes in biological 
responding to exercise. Clinical implications include the potential benefit of gender-tailored 
strategies to reduce distress vulnerability.  
Appropriately, Study 2 evaluated hot hatha yoga as a tailored intervention strategy for 
women with problems characterized by elevated stress coupled with poor affect regulation (i.e., 
resulting in stress-induced eating tendencies). Study 2 extended initial work on the efficacy of 
exercise for AS by targeting a novel application of yoga for enhancing low emotional DT. We 
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also found that reduced DT was an explanatory mechanism of psychopathology symptom 
reductions observed with yoga (Study 2). Specifically, this study showed an 8-week yoga 
intervention effectively increased DT and reduced emotional eating tendencies. Moreover, 
mediation analyses confirmed enhanced-DT as a driving mechanism of emotional eating 
changes. This finding builds off of the body of evidence supporting exercise for enhancing DT 
(Broman-Fulks et al., 2004; Broman-Fulks & Storey, 2008; Smits et al., 2008), while extending 
the evidence to the modality of yoga. 
In light of their findings and the call to consider multiple avenues by which yogic 
exercise can address the contribution of DT substance relapse, the aim of Study 3 was to 
examine biobehavioral pathways of yoga’s potential for reducing risk of early relapse in women 
with low DT (high-AS). We aimed to do so by targeting cortisol levels with 8-week, twice 
weekly Vinyasa yoga (a dynamic, moderate-to-vigorous intensity yoga style). We hypothesized 
yoga would regulate cortisol secretion patterns in the HPA-axis from pre-to-post intervention so 
that prior to a quit-attempt, so that during a quit-attempt typical drops in cortisol during 
withdrawal would be attenuated. We predicted that reduced subjective nicotine withdrawal-
symptoms and smoking cessation success (i.e., lengthier abstinence duration) would accompany 
these effects. By investigating mediators of the effects of hatha yoga, the broader goal of Study 3 
was to translate important basic experimental research findings to early-stage intervention 
development efforts. Ultimately, results indicated 8-week hatha Vinyasa yoga was not effective 
for targeting cortisol, ameliorating withdrawal, or achieving abstinence in smokers. Two likely 
confounds limiting the efficacy of our intervention were attrition and poor intervention 
adherence.  
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Novel Contributions to the Literature. Despite null findings on major aims for Study 3, 
our results showed that diurnal cortisol patterns for each assessment day (baseline, post-
intervention, quit day) were in accordance with the normal trajectory of decline that occurs from 
morning to evening (Edwards, Clow, Evans, & Hucklebridge, 2001). Furthermore, results 
regarding the difference between pre-and post-quit cortisol levels in successful abstainers 
replicated previous research findings showing an acute cortisol decline results from nicotine 
deprivation (Cohen, al ‘Abasi, & Collins, 2004; Frederick et al., 1998; Ussher et al., 2006). 
These findings add to the literature demonstrating reliability for examining diurnal cortisol 
patterns over repeated measurement points.  
Our exploratory finding also adds to smoking cessation literature. Participants were not 
explicitly instructed to alter their smoking habits leading up to quit day, however, we considered 
this a possibility given their involvement in a health behavior change intervention (Prochaska, 
Spring, & Nigg, 2008). Interestingly, we found that yoga facilitated during-intervention 
reductions over time in cigarette smoking (i.e., tapering). This suggests yoga may be a useful 
preparatory aid for quitting smoking. Alternatively, this argues for yoga as a harm reduction 
intervention for smokers not motivated for complete cessation.  
Implications for Exercise Intervention Implementation 
Population-specific adherence barriers should be identified and addressed. Research 
suggests that some of the characteristics specific to our samples may make it challenging for 
them to initiate and adhere to behavioral interventions. In fact, the nature of characteristics 
specific to those with AS (i.e., fear of autonomic arousal and its consequences) can lead to 
anxious avoidance of exercise specifically (Broocks et al., 1997). In Study 2, a secondary 
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publication from the parent trial showed that BMI and low DT significantly predicted of weekly 
adherence (Baird et al., 2015). This highlights a paradoxical challenge that a major characteristic 
we aim to target with exercise has potential to prevent many from having the chance to benefit. 
Study 3 findings prompts for further examination of moderator characteristics, including BMI 
and DT, as determinants of adherence to Vinyasa yoga.  
It is suggested in the literature that BMI may be a particularly important aspect to 
consider in the context of programmed exercise for women low in DT. Previous findings indicate 
that individuals with higher BMI tend to enjoy exercise less than normal-eight individuals. 
Specifically, as exercise intensity increases, overweight and obese individuals experience more 
aversive somatic sensations and greater during-exercise negative affect (Ekkekakis & Lind, 
2006). Importantly, tendency to associate the experience of exercise with negative consequences 
can deter future exercise performance. Moreover, high BMI individuals with AS have shown to 
experience greater levels of fear during exercise (Smits et a., 2010). This work suggests that BMI 
may be a particular in the exercise adherence of patients with predisposed vulnerability to 
aversive somatic and/or affective states.  
Second, women are more likely than men to present with body image concerns and 
disordered eating patterns related to self-objectification (Cash, Theriault, & Annis, 2004) and 
fear of negative evaluation (DeBoer & Smits, 2013; DeBoer et al., 2013) that could impede their 
engagement in community-based exercise. Exercising in a group setting has potential to trigger 
such concerns. Though popular and appealing for many, the stereotypes associated with yoga in 
particular (e.g., thin, flexible body ideal), could feasibly exacerbate exercise avoidance. 
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Though BMI was in the healthy range in our sample, fear of weight gain is a significant 
reason many smokers, particularly women, are reticent to quit smoking (Pomerleau, Zucker, & 
Stewart, 2001). This further highlights the salience of addressing body image and weight control 
in low DT smokers. The CBT intervention in the trial conducted by Bock et al. (2012) 
specifically included a module for addressing weight concern. We suspect that weight concern 
may be an important variable impacting the effects of yoga on smoking cessation outcomes.  
To address acute negative affect during exercise and fear of exercise, adding components 
of mindfulness and exposure-based interventions may help to target such behavioral barriers, 
while also potentially augmenting the exercise-DT relation. As a pre-intervention strategy, these 
techniques may help to modify anxious apprehension and experiential avoidance, thereby 
helping participants ease into and better-tolerate an exercise program.  
Acceptance and Commitment Therapy (ACT; Hayes, 2003) is one mindfulness-based 
approach that may be particularly effective when combined with exercise. By 
integrating mindfulness awareness practices with committed action to personal values, ACT may 
serve as a motivational tool to behaviorally persist in the face of distress. Initial support for the 
utility of ACT in smokers comes from Brown and colleagues, who conducted a pilot trial 
evaluating mindful acceptance-based augmentation to standard CBT to target DT in smokers 
with a history of repeated relapse (Brown et al., 2013). Among those who completed the trial, 
81% were able to remain abstinent for longer than 72 hours, and 43% maintained abstinence for 
over one month (Brown et al., 2013).  
Finally, there is reason to investigate not only negative, but also positive clinical 
predictors of adherence. For example, we suspect that some of the non-specific factors that 
 102 
enhance adherence in clinical therapy (e.g., rapport and therapeutic alliance; Martin, Garske, & 
Davis, 2000) may also help participants engage in exercise. It is possible that the low attrition 
observed in Study 1 was in part related to face-to-face attention and contact (i.e., participants 
reported to familiar clinical laboratory staff for their sessions). Though providing yoga in a 
similar context may have helped lower attrition, it is important to continue developing and 
delivering interventions in naturalistic settings to enhance generalizability of findings. Strategies 
to important to consider ways to help participants to feel generally accepted and supported at 
their place of exercise to effectively perform yoga in the community. Other positive predictors of 
yoga/exercise adherence worth investigation that stem from the positive psychology literature 
include self-compassion, mindfulness, and resilience (Gard et al., 2012; di Manincor et al., 
2016).     
Adherence, and therefore, efficacy may depend on aspects of study design and 
measurement. Our three RCTs varied based on intervention length (2, 8 week), exercise 
modality (yoga, aerobic running), session dose (60 vs. 90 minutes) and distress intolerant 
population of interest (men/women with AS; women with stress-eating tendencies; female 
tobacco smokers with AS). We suspect that the differential attrition and adherence observed 
across studies could be related to their procedural variations.  
In studies conducted in AS samples, contrasting attrition rates were observed (21% and 
38% for Study 1 and Study 3, respectively). One possibility is that a 2-week intervention is more 
feasible for populations with AS than lengthier exercise interventions. Furthermore, exercise 
sessions in Study 1 were conducted onsite and facilitated/supervised by laboratory clinicians, 
guiding participants through exercise-based somatic “exposure” sessions. In addition, 
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participants were oriented to the distress exposure by providing incremental distress ratings 
during their exercise sessions. It is possible that having clinician support/contact while 
participants attended to uncomfortable sensations bolstered during-exercise effort and confidence 
in being able to remain in the session and intervention.   
Regarding session dose, we chose to employ 60-minute sessions in Study 3 (i.e., as 
opposed to 90-minute sessions employed in Study 2) to balance potential for efficacy with 
feasibility. However, still, we did not have positive outcomes related to intervention adherence 
efficacy. Comparatively, Study 2 showed efficacy for targeting emotional DT using 90-minute 
sessions. Moreover, the parent study for Study 2 showed that this yoga dose was able to target 
cortisol (Hopkins et al., 2016). It is possible that longer yoga sessions may be required to alter 
HPA-axis functioning dysregulations associated with habitual nicotine use. Alternatively, it is 
possible that the 8-week delay in re-assessing cortisol after baseline prevented us from capturing 
meaningful changes that occurred during the intervention, particularly during weeks when great 
yoga class attendance was observed. Employing a briefer yoga intervention or assessing cortisol 
more frequently and in close proximity following yoga performance (as was the case in Study 1) 
may improve the likelihood of detecting effects. Ultimately, the lack of analogous trials for 
comparison in the area of yoga for cortisol in smokers suggests future research will benefit from 
testing a variety of designs and procedures.  
 Health behavior change research may guide integrative approaches for achieving 
adherence to an exercise intervention. Some evidence in the health behavior literature suggests 
physical activity interventions can be efficacious for achieving multiple health behavior change 
(Prochaska, Spring, & Nigg, 2008). However, it may be overly ambitious to expect to tackle one 
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difficult-to-change health behavior (i.e., quitting smoking) with another (i.e., exercise adoption). 
Together, the literature in healthy populations, as well as in those with affective vulnerabilities, 
reinforce the effectiveness of implementing exercise from a multifaceted approach. Results from 
the trial by Bock et al., (2012) suggests that in addition to standard evidence based counseling 
(i.e., CBT), integrating mechanisms for social support and accountability into the program 
structure can be useful. Other empirically sound approaches for exercise implementation 
incorporate proven strategies for achieving successful behavior change. Self-efficacy, beliefs 
about treatments, and motivational readiness are three major targets of such techniques (Riekert, 
Ockene, & Pbert, 2013).  
Future Directions 
In light of the findings and the limitations of each of the studies, discussed in turn, we 
offer several next-step recommendations for future studies. Non-significant findings in Study 3 
highlight the difficulty in studying biobehavioral mechanisms of intervention outcome. Indeed, 
there are a complex and dynamic interplay of factors involved in HPA-axis functioning with 
implications for impacting cortisol levels. We advise future studies to incorporate large sample 
sizes to reduce sample heterogeneity. In addition, future attempts to specifically examine during-
withdrawal cortisol may consider measuring and controlling for other, potentially competing 
influences on HPA activity. Given that quitting smoking is stressful, one potentially important 
factor to consider in future research studies examining withdrawal is acute stress. There is 
evidence that nicotine and acute stress can interact to potentiate HPA-axis release of cortisol 
(Pomerleau & Pomerleau, 1990). The link between perceived stress and nicotine deprivation in 
predicting cortisol levels is not clear. However, future studies should investigate this. At the 
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least, future treatment studies should aim to differential the effects of their intervention on 
withdrawal-related cortisol levels from those of stress. 
To determine the comparative efficacy of yoga in DT-related conditions, intervention 
trials are needed comparing yoga and exercise to active control conditions. In addition, trials will 
be needed to test dose-response effects for yoga. This will require manipulating adherence to 
predict differential efficacy based on yoga performance. Dose efficacy studies should be 
conducted in predicting a range of possible biobehavioral outcomes (e.g., DT, AS, HPA-axis 
functioning) and in a range of populations with behavioral addictions and other conditions that 
may benefit. Furthermore, large-scale studies will be needed to determine the cost-effectiveness 
of yoga. These trials will also help to pinpoint for whom practicing yoga over traditional exercise 
(or vice versa) is preferred. Finally, given that our results on yoga only extend to women, future 
studies are warranted to examine effect of yoga on cortisol and nicotine withdrawal in low DT 
men.   
Conclusion 
Previous research calls for improving the effectiveness, feasibility, and tolerability of 
treatments for substance and non-substance-related addictive disorders. Novel interventions are 
particularly warranted that can address the contribution of low DT to addiction maintenance, 
relapse, and treatment attrition. Treatments for enhancing DT in psychopathology to date have 
involved mindful acceptance and behavioral exposure; and so far, these techniques appear 
effective in low DT substance users with tobacco addiction. Exercise (especially of the aerobic 
type) emerges as another efficacious behavioral candidate for addressing low DT. In addition, 
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exercise holds practical and health-promoting potential for addressing public health burden of 
SUDs.  
Guided by this background of literature, we conducted three RCTs that aimed to target 
biobehavioral factors implicated in the role of affective vulnerability in addiction maintenance 
and relapse. These trials represent important steps to extend the application of exercise and yoga 
to treat distress vulnerable groups, namely those at-risk for anxiety disorders and addictive 
behaviors (eating, tobacco use).  
Because prescribed exercise and yoga will be most effective in its clinical application 
when reserved for patients who are prone to benefit, future efforts should continue to focus on 
identifying moderators and mechanisms of response with adjunct and stand-alone exercise, and 
to compare their effects. We encourage these pursuits particularly within affect-vulnerable 
populations prone to addictive disorders who warrant improved intervention strategies. Exercise-
ready candidates will also be those sufficiently motivated for behavioral change and who can 
functionally tolerate vigorous physical exertion. Pinpointing these groups and addressing each of 
their individually tailored needs and preferences through the appropriate exercise dose, modality 
(e.g., running, yoga), and therapeutic mechanism will require continued empirical efforts. 
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